<!DOCTYPE html>

<!--[if lt IE 7]>      <html class="no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]-->
<!--[if IE 7]>         <html class="no-js lt-ie9 lt-ie8"> <![endif]-->
<!--[if IE 8]>         <html class="no-js lt-ie9"> <![endif]-->
<!--[if gt IE 8]>      <html class="no-js"> <![endif]-->

<!--[if gt IE 8]><!-->
<html class="no-js" prefix="og: http://ogp.me/ns#">
<!--<![endif]-->

<head>
<title>Functional analysis of Zyxin in cell migration and invasive potential of oral squamous cell carcinoma cells Corrigendum in /10.3892/ijo.2016.3702</title>
<meta http-equiv="content-type" content="text/html; charset=UTF-8" />
<meta charset="utf-8" />
<meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1" />

<meta name="citation_doi" content="10.3892/ijo.2013.1761" />
<meta name="citation_journal_title" content="International Journal of Oncology" />
<meta name="citation_title" content="Functional analysis of Zyxin in cell migration and invasive potential of oral squamous cell carcinoma cells Corrigendum in /10.3892/ijo.2016.3702" />

	<meta name="citation_author" content="Yamamura,Michiyo " />
	<meta name="citation_author_institution" content="Department of Oral and Maxillofacial Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan" />

	<meta name="citation_author" content="Noguchi,Kazuma " />
	<meta name="citation_author_institution" content="Department of Oral and Maxillofacial Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan" />

	<meta name="citation_author" content="Nakano,Yoshiro " />
	<meta name="citation_author_institution" content="Department of Genetics, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan" />

	<meta name="citation_author" content="Segawa,Emi " />
	<meta name="citation_author_institution" content="Department of Oral and Maxillofacial Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan" />

	<meta name="citation_author" content="Zushi,Yusuke " />
	<meta name="citation_author_institution" content="Department of Oral and Maxillofacial Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan" />

	<meta name="citation_author" content="Takaoka,Kazuki " />
	<meta name="citation_author_institution" content="Department of Oral and Maxillofacial Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan" />

	<meta name="citation_author" content="Kishimoto,Hiromitsu " />
	<meta name="citation_author_institution" content="Department of Oral and Maxillofacial Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan" />

	<meta name="citation_author" content="Hashimoto-Tamaoki,Tomoko " />
	<meta name="citation_author_institution" content="Department of Genetics, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan" />

	<meta name="citation_author" content="Urade,Masahiro " />
	<meta name="citation_author_institution" content="Department of Oral and Maxillofacial Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan" />


<meta name="citation_publication_date"
	content="2013-03-01" />
<meta name="citation_volume" content="42" />
<meta name="citation_issue" content="3" />
<meta name="citation_firstpage" content="873" />
<meta name="citation_lastpage" content="880" />
<meta name="citation_publisher" content="Spandidos Publications" />
<meta name="citation_issn" content="1019-6439" />
<meta name="citation_abstract_html_url" content="http://www.spandidos-publications.com/10.3892/ijo.2013.1761/abstract" />
<meta name="citation_pdf_url" content="http://www.spandidos-publications.com/10.3892/ijo.2013.1761/download" />
<meta name="citation_fulltext_world_readable" content="" />

<meta name="keywords"
	content="cancer, oncology, oncogene, molecular medicine, tumor, apoptosis, gene, cell, research, scientific journals, tumour suppressor genes, cell cycle, growth factors" />
<meta name="verify-v1"
	content="qIInQfvSmbVNPO1nn+hEr0GnchYI4j93np2wrWGr29A="></meta>
<meta name="verify-v1"
	content="KOd/fzGN2I+RDbonO/qYB3yaji9QcOddBCxBKx+5j9U="></meta>
	
	
 <meta name="twitter:card" content="summary"></meta>
 <meta name="twitter:title" content="Functional analysis of Zyxin in cell migration and invasive potential of oral squamous cell carcinoma cells Corrigendum in /10.3892/ijo.2016.3702"></meta>
 <meta name="twitter:site" content="https://www.spandidos-publications.com/10.3892/ijo.2013.1761"  />
 <meta name="twitter:image" content="https://www.spandidos-publications.com/resources/images/ijo.jpg"/>	
 <meta name="twitter:description" content="Zyxin is an evolutionarily conserved protein that has been implicated in the regulation of actin assembly and is mainly located at focal adhesions. However, the biological roles of Zyxin in cancer cells are incompletely understood. We analyzed the functions of Zyxin in cell migration and the invasive potential of OSCC. Zyxin expression was examined using eight OSCC cell lines with two different cell morphologies (6 epithelial type and 2 fibroblastic type). To knockdown Zyxin expression, OSCC cells were transfected with Zyxin siRNA and control siRNA. The cell lines were studied by western blot analysis, immunocytochemical analysis and cell migration and invasion assay. Epithelial type OSCC cells showed a high level of E-cadherin expression and a low level of Zyxin expression. N-cadherin as well as Zyxin were strongly expressed in fibroblastic type OSCC cells. Expression levels of LPP and TRIP6, members of the human Zyxin family, did not differ between epithelial type and fibroblastic type. Knockdown of Zyxin expression by siRNA in fibroblastic type OSCC cells was associated with cell morphological changes from spindle (fibroblastic) to polygonal (epithelial) shape and significantly inhibited cell growth as well as cell migration and invasion. Expression levels of Rac1 and Cdc42 were weaker in Zyxin siRNA-treated fibroblastic type OSCC cells than in control siRNA-treated cells, but the expression of RhoA did not differ significantly. Treatment of fibroblastic type OSCC cells with Rac1 inhibitor decreased the expression of Zyxin mRNA and protein. Zyxin is suggested to promote growth, migration and invasiveness of fibroblastic type OSCC cells by upregulating Rac1 and Cdc42."/>	
 

 <meta property='og:title' content="Functional analysis of Zyxin in cell migration and invasive potential of oral squamous cell carcinoma cells Corrigendum in /10.3892/ijo.2016.3702"/>
 <meta property='og:image:secure_url' content="https://www.spandidos-publications.com/resources/images/ijo.jpg"/>
 <meta name="image" property='og:image' content="https://www.spandidos-publications.com/resources/images/ijo.jpg"/>
 <meta property="og:image:width" content="200" /> 
 <meta property="og:image:height" content="200" />
 <meta property="og:image:type" content="image/jpg" />
 <meta property='og:description' content="Zyxin is an evolutionarily conserved protein that has been implicated in the regulation of actin assembly and is mainly located at focal adhesions. However, the biological roles of Zyxin in cancer cells are incompletely understood. We analyzed the functions of Zyxin in cell migration and the invasive potential of OSCC. Zyxin expression was examined using eight OSCC cell lines with two different cell morphologies (6 epithelial type and 2 fibroblastic type). To knockdown Zyxin expression, OSCC cells were transfected with Zyxin siRNA and control siRNA. The cell lines were studied by western blot analysis, immunocytochemical analysis and cell migration and invasion assay. Epithelial type OSCC cells showed a high level of E-cadherin expression and a low level of Zyxin expression. N-cadherin as well as Zyxin were strongly expressed in fibroblastic type OSCC cells. Expression levels of LPP and TRIP6, members of the human Zyxin family, did not differ between epithelial type and fibroblastic type. Knockdown of Zyxin expression by siRNA in fibroblastic type OSCC cells was associated with cell morphological changes from spindle (fibroblastic) to polygonal (epithelial) shape and significantly inhibited cell growth as well as cell migration and invasion. Expression levels of Rac1 and Cdc42 were weaker in Zyxin siRNA-treated fibroblastic type OSCC cells than in control siRNA-treated cells, but the expression of RhoA did not differ significantly. Treatment of fibroblastic type OSCC cells with Rac1 inhibitor decreased the expression of Zyxin mRNA and protein. Zyxin is suggested to promote growth, migration and invasiveness of fibroblastic type OSCC cells by upregulating Rac1 and Cdc42."/>	
 <meta property='og:url' content="https://www.spandidos-publications.com/10.3892/ijo.2013.1761"/>

<link rel="stylesheet" type="text/css" media="all"
	href="/resources/css/styles.css" />
<link rel="stylesheet" href="/resources/css/jquery.fancybox.css"
	type="text/css" />

<!--[if IE 7]>  <link rel="stylesheet" type="text/css" href="/resources/css/ie7.css"> <![endif]-->
<script src="/resources/js/modernizr-3.3.1.min.js"
	type="text/javascript"></script>

</head>

<body class="ijo">

	<!--[if lt IE 7]>
        <p class="chromeframe">You are using an outdated browser. <a href="http://browsehappy.com/">Upgrade your browser today</a> or <a href="http://www.google.com/chromeframe/?redirect=true">install Google Chrome Frame</a> to better experience this site.</p>
    <![endif]-->

	
	
	<div class="wrapper">

		<div>
		<div class="super wide d-flex pb-4">
			<div class="super fixed_width">
				<ul  >
					<li><a href="/home">Home</a></li>
					
					
					<li><a href="/osats">Submit Manuscript</a></li>
					<!-- <th:block th:if="${session != null and session.user != null and session.user.type == 'user'}"> 
						<li th:if="${session.user.maxYearlyReviews} gt 0" ><a href="/reviews">Reviews</a></li>
					</th:block> -->
					<li><a href="/myaccount">My Account</a></li>
				</ul>			
			</div>
		</div>
	
		<div class="header wide">
			<div class="header fixed_width">
				<div class="header_logo">
					<a href="/home"><img src="/resources/images/spandidoslogo.png"/></a>
				</div>

				<div class="header_search">

					<div id="searchbtn">
						<a href="/advancedsearch/ijo">Advanced Search</a>
						
					</div>
					
					<div  class="searchbox">
							
							<a href="javascript:BasicSearch(&#39;ijo&#39;)"   ><img  src="/resources/images/searchbutton.png"/></a>
							
							<input class="" type="text" id= "searchFor" />		
					</div>
					
					<div> 
						
						
						<ul >
							<li><a href="/register">Register</a></li>
							<li><a href="/login" id="loginLink">Login</a></li>							
						</ul>
						
						
						
					</div>		
					
					
					
				</div>
				<div class="header_nav">
					<ul>
						<li style="width: 8.3%;" class="ol"><a href="/ol">Oncology <br />Letters</a></li>
						<li style="width: 8.3%;" class="ijo"><a href="/ijo">International <br />Journal <br />of Oncology</a></li>
						<li style="width: 8.3%;" class="mco"><a href="/mco">Molecular <br />and Clinical <br />Oncology</a></li>
						<li style="width: 8.3%;" class="etm"><a href="/etm">Experimental <br />and Therapeutic <br />Medicine</a></li>
						<li style="width: 8.3%;" class="ijmm"><a href="/ijmm">International <br />Journal <br />of Molecular <br />Medicine</a></li>
						<li style="width: 8.3%;" class="br"><a href="/br">Biomedical <br />Reports</a></li>
						<li style="width: 8.3%;" class="or"><a href="/or">Oncology <br />Reports</a></li>
						<li style="width: 8.3%;" class="mmr"><a href="/mmr">Molecular <br />Medicine <br />Reports</a></li>						
						<li style="width: 8.3%;" class="wasj"><a  href="/wasj">World Academy <br />of Sciences <br />Journal</a></li>
						<li style="width: 8.3%;" class="ijfn"><a  href="/ijfn">International <br />Journal <br />of Functional<br />Nutrition</a></li>
						<li style="width: 8.3%;" class="ije"><a  href="/ije">International <br />Journal <br />of Epigenetics</a></li>
						<li style="width: 8.3%;" class="mi"><a  href="/mi">Medicine <br />International </a></li>
					</ul>
				</div>                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
			</div>
		</div>
		
		<!-- Journal and Article pages show Journal banner -->
		<div class="banner wide flex">
			<div class="banner fixed_width">
				
				<h1>International<br/>Journal of<br />Oncology</h1>
				
				
				
				
				
				
				
				
				
				
				<img src="/resources/images/bannerijo.jpg" alt="Journal Banner" />
			</div>
		</div>		
	</div>

		<div class="content wide">
			<div class="content fixed_width">
				<div class="content_sidebar">
				<ul class="sidebar_journal_top">
					<li class="sidebar_title"><a href="/ijo">Journal Home</a></li>
					<li >
						<a href="/ijo">Current Issue</a>
					</li>
					<li>
						
						<a href="/ijo/forthcoming">Forthcoming Issue</a>
					</li>
					<li>
						<a id="toggleSpecialIssue" href="#" onclick="$('.toggleSpecialIssue').toggle();return false;">Special Issues</a>
						<ul class="toggleSpecialIssue" style="display:none; margin-bottom: 0px; border:0px ">
							<li><a href="/ijo/specialIssues/open">Open Special Issues</a></li>
							
							<li><a href="/pages/ijo/specialissues">About Special Issues</a></li>
							<li><a href="/osats">Submit Paper</a></li>
						</ul>
					</li>
					
					<li><a href="/ijo/mostread">Most Read</a></li>
					<li>
						<a id="toggleMostCitedDimensions" href="#" onclick="return false">Most Cited (Dimensions)</a>
						<ul class="toggleMostCitedDimensions" style="display:none; margin-bottom: 0px; border:0px ">
							<li><a href="/ijo/mostciteddimensionrecent">Past Two Years</a></li>
							<li><a href="/ijo/mostciteddimension">Total</a></li>
						</ul>
					</li>
					<li><a id="toggleMostCitedCrossRef" href="#" onclick="return false">Most Cited (CrossRef)</a>
						<ul class="toggleMostCitedCrossRef" style="display:none; margin-bottom: 0px; border:0px ">
							<li><a href="/ijo/mostcitedbylastyear">Past Year <span  class="rightsReservedCrossref">0 </span></a></li>
							<li><a href="/ijo/mostcitedby">Total</a></li>
						</ul>
					</li>
					<li><a id="toggleSM" href="#toggleSM" onclick="return false">Social Media</a>
						<ul class="toggleSM" style="display:none; margin-bottom: 0px; border:0px ">
							<li><a class="medium" href="/ijo/1m/mostaltmetricmentions">Past Month</a></li>
							<li><a class="medium" href="/ijo/1y/mostaltmetricmentions">Past Year</a></li>
							<li><a class="medium" href="/ijo/at/mostaltmetricmentions">Total</a></li>
						</ul>
					</li>
					 <li><a href="/ijo/archive">Archive</a></li>
				</ul>
				<ul class="sidebar_journal_bottom">
					<li class="sidebar_title">Information</li>
					<li><a href="/osats">Online Submission</a></li>
					<li><a href="/pages/ijo/info_for_authors">Information for Authors</a></li>
					<li><a href="/languageediting">Language Editing</a></li>
					<li><a href="/pages/info_for_reviewers">Information for Reviewers</a></li>
					<li><a href="/pages/ijo/editorialPol">Editorial Policies</a></li>
					
					<li>
						
						<a href="/pages/ijo/editorial">Editorial Academy</a>
						
					</li>
					<li>
						
						<a href="/pages/join_editorial">Join Editorial Academy</a>
						
					</li>
					
					<li><a href="/pages/ijo/aims_scope">Aims and Scope</a></li>
					<li><a href="/pages/ijo/abstracting" id="abstracting" class="staticContent">Abstracting and Indexing</a></li>
					<li><a href="/pages/ijo/bibliographic">Bibliographic Information</a></li>
					<li><a href="/pages/info_for_librarians">Information for Librarians</a></li>
					<li><a href="/pages/info_for_advertisers">Information for Advertisers</a></li>	
					<li><a href="/pages/reprints">Reprints and permissions</a></li>						
					<li><a href="/pages/ijo/contact">Contact the Editor</a></li>
				</ul>
				
				<ul class="sidebar_journal_bottom">
						<li class="sidebar_title">General Information</li>
						<li><a href="/pages/about">About Spandidos</a></li>
						<li><a href="/pages/conference">Conferences</a></li>
						<li><a href="/pages/jobs">Job Opportunities</a></li>
						<li><a href="/pages/contact">Contact</a></li>
						<li><a href="/pages/terms">Terms and Conditions</a></li>
				 </ul>	
			</div>

				<div class="content_main">
					<div class="content_article">
					
					
						

						

						
							<h1>Functional analysis of Zyxin in cell migration and invasive potential of oral squamous cell carcinoma cells </h1>
							
							<h2>
								<span class="red">Corrigendum in:</span> <a href="/10.3892/ijo.2016.3702">/10.3892/ijo.2016.3702</a>
							</h2>
							
							
														
							
						

						

						

						<ul class="article_details">
						
						    
						
							<li><span class="bold">Authors:</span>
								<ul id="authorshipNames">
									
										
										<li>Michiyo  Yamamura</li>
									
										
											
												<li class="corresponding"
													title="knoguchi@hyo-med.ac.jp">Kazuma  Noguchi</li>
											
										
										
									
										
										<li>Yoshiro  Nakano</li>
									
										
										<li>Emi  Segawa</li>
									
										
										<li>Yusuke  Zushi</li>
									
										
										<li>Kazuki  Takaoka</li>
									
										
										<li>Hiromitsu  Kishimoto</li>
									
										
										<li>Tomoko  Hashimoto-Tamaoki</li>
									
										
										<li>Masahiro  Urade</li>
									
								</ul>
							</li>

							<li><p>
									<a class="bold" href="#" id="toggle">View Affiliations</a>
								</p>

								<div class="toggle" style="display: none;">
									<br /> <span class="bold">Affiliations: </span><span>Department of Oral and Maxillofacial Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan, Department of Genetics, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan</span>
								</div></li>

							<!--<li><span class="bold">Corresponding author:</span> <span th:text="${dispArt.correspondingList}">Author name</span></li>-->
							<li><span class="bold">Published online on:</span> <span
								id="publishedOn">January 4, 2013</span> <span>&nbsp;&nbsp;&nbsp;</span> <span
								id="doi">https://doi.org/10.3892/ijo.2013.1761</span>
							</li>

							<li>
								
									<span  class="bold">Pages: </span>
									<span>873-880</span>
								
								
								
								</li>

							
						</ul>



						<div>

							<div id="metrics">
								<div>
									<span title="The metrics are calculated only from this site"
										class="bold">Metrics: </span> <span class="small"
										title="The metrics are calculated only from this site">Total
										Views: </span> <span
										title="The metrics are calculated only from this site"
										class="bold small" id="postTotalFullArticleViews">0 </span> <span
										class="small">(Spandidos Publications:</span> <span
										class="bold small" id="postFullArticleViews"></span> <span
										class="small"> | PMC Statistics: </span> <span
										class="bold small" id="postPMCFullArticleViews"></span> <span
										class="small">)</span>

									<div>
										<span style="visibility: hidden;"
											title="The metrics are calculated only from this site"
											class="bold">Metrics: </span> <span
											title="The metrics are calculated only from this site"
											class="small">Total PDF Downloads: </span> <span
											title="The metrics are calculated only from this site"
											id="postTotalArticleDownloads" class="bold small">0 </span> <span
											class="small">(Spandidos Publications:</span> <span
											class="bold small" id="postArticleDownloads"></span> <span
											class="small"> | PMC Statistics: </span> <span
											class="bold small" id="postArticlePMCDownloads"></span> <span
											class="small">)</span>
									</div>

								</div>



							</div>
							<div>
								<span id="citationCountId"> <a class="citedByCountId"
									style="margin-left: 0px"
									href="/getTotalCount/10.3892/ijo.2013.1761"></a>
								</span>
								<span id="citation"> <a class="citedBy"
									style="margin-left: 0px"
									href="/citationhtml/10.3892/ijo.2013.1761/html">
										Cited By (CrossRef): </a>
								</span> <span class="bold small" id="citationCount">0</span> <span
									class="bold small"> citations </span>
								<span class="bold small citationAllArticlesClass" id="citationAllArticlesId">
									<a id="citedByIdViewArticles" class="citedBy"
									style="font-size: 15px; text-decoration: none; margin-left: 0px"
									href="/citationhtml/10.3892/ijo.2013.1761/html">
										Loading Articles... </a>
								</span> 
							</div>

							<a class="moreLikeThis" style="display: none"
								href="/morelikethis/23585"></a>

							<div id="citationDiv" style="display: none">
								<h4>This article is mentioned in:</h4>
								<div id="citations"></div>
							</div>

							<span class="__dimensions_badge_embed__"
								data-hide-zero-citations="true" data-legend="always"
								data-style="small_circle" data-doi="10.3892/ijo.2013.1761"></span>
							<script async="async" src="https://badge.dimensions.ai/badge.js"
								charset="utf-8"></script>
							<br></br> <span data-hide-no-mentions="true"
								data-badge-details="right" class='altmetric-embed'
								data-badge-type="donut" data-link-target="_blank" data-doi="10.3892/ijo.2013.1761"></span>
						</div>


						<h4>Abstract</h4>

						


						<div
							id = "articleAbstract">Zyxin is an evolutionarily conserved protein that has been implicated in the regulation of actin assembly and is mainly located at focal adhesions. However, the biological roles of Zyxin in cancer cells are incompletely understood. We analyzed the functions of Zyxin in cell migration and the invasive potential of OSCC. Zyxin expression was examined using eight OSCC cell lines with two different cell morphologies (6 epithelial type and 2 fibroblastic type). To knockdown Zyxin expression, OSCC cells were transfected with Zyxin siRNA and control siRNA. The cell lines were studied by western blot analysis, immunocytochemical analysis and cell migration and invasion assay. Epithelial type OSCC cells showed a high level of E-cadherin expression and a low level of Zyxin expression. N-cadherin as well as Zyxin were strongly expressed in fibroblastic type OSCC cells. Expression levels of LPP and TRIP6, members of the human Zyxin family, did not differ between epithelial type and fibroblastic type. Knockdown of Zyxin expression by siRNA in fibroblastic type OSCC cells was associated with cell morphological changes from spindle (fibroblastic) to polygonal (epithelial) shape and significantly inhibited cell growth as well as cell migration and invasion. Expression levels of Rac1 and Cdc42 were weaker in Zyxin siRNA-treated fibroblastic type OSCC cells than in control siRNA-treated cells, but the expression of RhoA did not differ significantly. Treatment of fibroblastic type OSCC cells with Rac1 inhibitor decreased the expression of Zyxin mRNA and protein. Zyxin is suggested to promote growth, migration and invasiveness of fibroblastic type OSCC cells by upregulating Rac1 and Cdc42.</div>

						<div>
							<div>



<h4>Introduction</h4>
<p>Oral squamous cell carcinoma (OSCC) is the sixth
most common neoplasm in the world, characterized by a poor
prognosis and low survival rates (<a href="#b1-ijo-42-03-0873" class="linksColor">1</a>,<a href="#b2-ijo-42-03-0873" class="linksColor">2</a>).
Worldwide, the GLOBOCAN 2002 database estimated that 274,000 new
cases of oral cancer and 127,000 deaths from the disease occur
annually [The GLOBOCAN 2002 database. International Agency for
Cancer Research (IARC), <a href="http://www-dep.iarc.fr/" class="linksColor">http://www-dep.iarc.fr/</a>]. In patients with locally
advanced disease, the main causes of treatment failure are
locoregional recurrence and metastatic disease. Despite recent
advances in diagnosis and surgical, radiotherapeutic, and
chemotherapeutic management, cervical lymph node involvement is
associated with an approximately 50% lower 5-year survival rate, as
well as an increased risk of distant metastasis (<a href="#b3-ijo-42-03-0873" class="linksColor">3</a>,<a href="#b4-ijo-42-03-0873" class="linksColor">4</a>).
Patients with highly invasive carcinomas have poor outcomes because
tumor cells deeply invade surrounding fibrous tissues, metastasize
more frequently to lymph nodes and are less sensitive to
chemotherapeutic agents than lowly invasive carcinomas. Invasion
and metastasis are thus the most crucial characteristics of
malignant tumors.</p>
<p>OSCC cell lines are important preclinical models in
the search for novel targeted therapies for oral cancer. Unlike
many other types of cancer, a wide variety of primary and
metastatic OSCC cell lines are available. In fact, more than 300
cell lines of head and neck cancer have been established, as
compared with approximately 70, 60 and 10 cell lines derived from
breast, colon and prostate cancers, respectively (<a href="#b5-ijo-42-03-0873" class="linksColor">5</a>,<a href="#b6-ijo-42-03-0873" class="linksColor">6</a>,<a href="#b7-ijo-42-03-0873" class="linksColor">7</a>).
Yokoyama <span class="italic">et al</span>(<a href="#b8-ijo-42-03-0873" class="linksColor">8</a>) reported
the establishment of subclonal OSCC cell lines that showed negative
expression of E-cadherin and fibroblastic spindle shape and had
higher invasive activity than the respective parental OSCC cell
lines. Moreover, they demonstrated that OSCC cell lines contained
two kinds of cells: one with an epithelial shape and the other with
a spindle or fibroblastic shape in culture. The cells with
epithelial shape expressed E-cadherin, whereas the cells with
fibroblastic shape did not. Frixen <span class="italic">et al</span>(<a href="#b9-ijo-42-03-0873" class="linksColor">9</a>) reported that carcinoma cell lines with
epithelial phenotype were non-invasive and expressed E-cadherin,
whereas carcinoma cell lines with fibroblastic phenotype were
invasive and had lost E-cadherin expression. These findings
indicate that OSCC is characterized by a heterogeneous cell
population. Fibroblastic type OSCC cells have been acknowledged to
result from epithelial-mesenchymal transition (EMT) in epithelial
cell lines, whereas the relation between cell morphology and tumor
cell motility in OSCC is incompletely understood.</p>
<p>Zyxin is an evolutionary conserved protein that has
been implicated in the regulation of actin assembly and is mainly
localized at focal adhesions. Zyxin is a family of proteins that
also includes lipoma preferred partner (LPP) and thyroid
receptor-interacting protein-6 (TRIP-6) (<a href="#b10-ijo-42-03-0873" class="linksColor">10</a>,<a href="#b11-ijo-42-03-0873" class="linksColor">11</a>).
Although Zyxin has been shown to be diffusely distributed in
cytoplasm, it is likely that part of Zyxin enters the nucleus,
binds to h-warts and leads to G2-cell cycle arrest and inhibition
of proliferation, as observed after silencing of LASP-1, a
transcriptional factor of Zyxin (<a href="#b12-ijo-42-03-0873" class="linksColor">12</a>,<a href="#b13-ijo-42-03-0873" class="linksColor">13</a>).
Zyxin is characterized by a nuclear-cytoplasmic shuttling of focal
contact proteins and has a potential mechanism for communication
between sites of cell adhesion and the nucleus (<a href="#b14-ijo-42-03-0873" class="linksColor">14</a>,<a href="#b15-ijo-42-03-0873" class="linksColor">15</a>,<a href="#b16-ijo-42-03-0873" class="linksColor">16</a>).
In cancer cells, Zyxin is significantly upregulated in melanoma
cells as compared with melanocytes, and Zyxin expression is
directly related to cell spreading and proliferation and inversely
related to differentiation (<a href="#b17-ijo-42-03-0873" class="linksColor">17</a>).
However, Sperry <span class="italic">et al</span>(<a href="#b18-ijo-42-03-0873" class="linksColor">18</a>)
found that expression of Zyxin activity is downregulated at
cell-cell junctions during EMT. Therefore, the biological roles of
Zyxin in cancer cells remain controversial. In this study, we
investigated the functions of Zyxin using eight OSCC cell lines
with two different cell morphologies (epithelial type and
fibroblastic type) to clarify the biological roles of Zyxin in
OSCC.</p>


<h4>Materials and methods</h4>

<h5>Cell culture and cell lines</h5>
<p>The eight oral squamous carcinoma cell lines [SCCKN
(<a href="#b19-ijo-42-03-0873" class="linksColor">19</a>), HSC-2, HSC-3 (<a href="#b20-ijo-42-03-0873" class="linksColor">20</a>), OSC-19 (<a href="#b21-ijo-42-03-0873" class="linksColor">21</a>), OSC-20 (<a href="#b22-ijo-42-03-0873" class="linksColor">22</a>), HOC-313, TSU (<a href="#b23-ijo-42-03-0873" class="linksColor">23</a>–<a href="#b25-ijo-42-03-0873" class="linksColor">25</a>)
and SCC25] were grown in DMEM containing 10% FBS as growth medium
and subcultured. OSC-19, OSC-20, HOC-313 and TSU were kindly
provided by Professor S. Kawashiri (Department of Oral and
Maxillofacial Surgery, Kanazawa University Graduate School of
Medical Science, Kanazawa, Japan).</p>


<h5>RNA extraction and real-time polymerase
chain reaction (PCR)</h5>
<p>Total-RNA was isolated using an RNeasy mini kit
(Qiagen, Valencia, CA, USA), and cDNAs were generated by using a
First-Strand cDNA Synthesis kit (Amersham Biosciences, Piscataway,
NJ, USA) with 2 <span class="italic">μ</span>g of total-RNA and oligo (dT) (GE
Healthcare Japan, Tokyo, Japan). All reagents required for
real-time PCR were from Applied Biosystems (Foster City, CA, USA).
Oligo-nucleotide primers and fluorescent probes for Zyxin and GAPDH
were designed using a primer design program (Primer Express,
Applied Biosystems) and were obtained from Integrated DNA
Technologies (Coralville, IA, USA).</p>


<h5>Protein preparation and western blot
analysis</h5>
<p>Cell lysates were submitted to western blot analysis
as described previously (<a href="#b26-ijo-42-03-0873" class="linksColor">26</a>,<a href="#b27-ijo-42-03-0873" class="linksColor">27</a>).
The following primary antibodies used: rabbit polyclonal antibodies
against Zyxin (Sigma-Aldrich Co., St. Louis, MO, USA), N-cadherin,
RhoA, CDC42 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), and
Rac1/2/3 (Cell Signaling Technology, Boston, MA, USA); mouse
monoclonal antibodies against E-cadherin (Santa Cruz
Biotechnology), LPP (Cell Signaling, Acc, Switzerland), and TRIP-6
(Abnoba, Taipei, Taiwan); and goat polyclonal antibodies against
actin (Santa Cruz Biotechnology). The secondary antibodies used
were anti-goat, anti-mouse or anti-rabbit IgGs conjugated with
alkaline phosphatase (all products, Santa Cruz Biotechnology).
Actin was used as an internal control.</p>


<h5>Immunocytochemical analysis</h5>
<p>The primary antibodies used in this study included
rabbit anti-Zyxin (Sigma-Aldrich) and mouse polyclonal antibody
against human actin (Santa Cruz Biotechnology). Cultured cells were
washed with PBS (-) twice and fixed in 3.7% paraformaldehyde for 20
min at room temperature. After blocking with 2% bovine serum
albumin, the cells were treated with a primary antibody at 4°C
overnight. The cells were washed and incubated with anti-rabbit
fluorescein isothiocyanate or anti-mouse rhodamine phalloidin
(Cytoskeleton, Denver, CO, USA), followed by counterstaining with
4,6-diamidino-2-phenylindole (DAPI). Finally, fluorescence images
were obtained by using a confocal laser microscope, LSM 510 version
3.2 (Carl Zeiss Co. Ltd., Oberkochen, Germany).</p>


<h5>Transfection of siRNAs</h5>
<p>Cells were cultured in DMEM supplemented with 10%
FBS for 24 h and then transfected with 5 <span class="italic">μ</span>M of siRNA, using
Thermo Scientific DharmaFECT Transfection Reagents (Roche,
Indianapolis, IN, USA) according to the manufacturer’s protocol.
SMART pool siRNA targeting Zyxin (L-016734-00-0020) and control
siRNA, On-Target plus GAPDH (D-001830-01-20), were purchased from
Dharmacon Inc. (Lafayette, CO, USA).</p>


<h5>Cell growth assay</h5>
<p>Cells were plated at 2.5×10<span class="superscript">4</span> cells/well
in 1-ml volumes in 12-well plates and cultured in growth medium at
37°C. At selected intervals, cell growth was determined by
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
assay or by using a hemocytometer as described previously (<a href="#b26-ijo-42-03-0873" class="linksColor">26</a>).</p>


<h5>Measurement of apoptosis</h5>
<p>Cells were plated at 3×10<span class="superscript">4</span> cells/well in
100-<span class="italic">μ</span>l volumes in 96-well plates and cultured in growth
medium at 37°C. Apoptosis induction was examined after 48 h using
an ssDNA Apoptosis ELISA Kit (Chemicon International Inc.,
Temecula, CA, USA).</p>


<h5>Flow cytometry</h5>
<p>For cell-cycle analysis, cells were harvested 48 h
after Zyxin siRNA transfection. The apoptosis index was measured
using a Cell Cycle Phase Determination kit (Cayman Chemical, Ann
Arbor, MI, USA).</p>


<h5>Scratch assay</h5>
<p>Cells were plated at 5×10<span class="superscript">5</span> cells/dish in
60-mm dishes (Asahi Techno Glass Co., Tokyo, Japan) and treated
with 25 nM Zyxin siRNA. Scratch assay was performed by scraping
confluent cell monolayers with a sterile pipette tip after 24 h.
Cell migration was examined by measuring the distance from edge to
edge after 6-h incubation.</p>


<h5>Invasion assay</h5>
<p>Cell invasion assay was carried out using BioCoat
Matrigel Invasion Chambers (Becton Dickinson, Bedford, MA, USA)
consisting of transwell membrane filter inserts in a 24-well tissue
culture plate. The transwell filter had an 8-<span class="italic">μ</span>m pore size
membrane coated with Matrigel. One hundred thousand cells were
seeded in the upper chamber of the transwell with serum-free DMEM
and treated with 25 nM Zyxin siRNA. DMEM containing 10% FBS was
added to the lower chamber after 24 h. Non-invading cells were
removed by wiping the upper side of the membrane, and invading
cells were fixed and stained with a Diff-Quick kit (Kokusaishiyaku
Co., Kobe, Japan) after 24-h incubation. The number of invading
cells per membrane was counted in triplicate under a light
microscope at x200 magnification in four fields per membrane.</p>


<h5>Expression of Zyxin after Rac1 inhibitor
treatment</h5>
<p>To examine the effect of Rac-1 inhibitor on
expression of Zyxin, cells were treated with 50 nM of Rac1
inhibitor (EHT 1864, R&amp;D Systems, IA, USA) for 4 h. Western
blot assay and real-time PCR analysis of Zyxin protein and mRNA in
HOC-313 cells were performed.</p>


<h5>Statistical analysis</h5>
<p>All values in the figures and text are expressed as
means ± SD. The results were analyzed and individual group means
were compared with the use of Student’s t-test. A p-value of
&lt;0.05 was considered to indicate statistical significance.</p>



<h4>Results</h4>

<h5>Expression of cadherins, Zyxin and Zyxin
family proteins in OSCC cell lines in relation to cell
morphology</h5>
<p>To examine the relations between the morphology of
OSCC cell lines and EMT markers, expressions of cadherins, Zyxin
and Zyxin family proteins were examined using western blot
analysis. All eight OSCC cell lines expressed EGFR, indicating that
these cell lines were of epithelial origin and not mesenchymal
origin. The OSCC cell lines showed two morphological types:
epithelial type cells such as SCCKN and HSC-2; and fibroblastic
type cells such as HOC-313 and TSU (<a href="#f1-ijo-42-03-0873" class="linksColor">Fig. 1</a>). Western blot analysis revealed
high expression levels of E-cadherin protein in 6 cell lines with
epithelial type morphology, including SCCKN, HSC-2, OSC-20, HSC-3,
OSC-19 and SCC25. These cell lines formed flatter colonies on the
plastic dish surface. In contrast, HOC-313 and TSU showed
fibroblastic morphology and were completely negative for
E-cadherin. These cell lines formed disperse colonies and expressed
N-cadherin, suggesting mesenchymal transition. To gain insight into
the functions of Zyxin family proteins in OSCC cell lines,
expressions of Zyxin and its family members LPP and TRIP-6 were
examined. The cell lines with epithelial type morphology and high
levels of E-cadherin expression showed low levels of Zyxin
expression. High levels of Zyxin and N-cadherin expression were
detected in cell lines with fibroblastic type morphology, such as
HOC-313 and TSU (<a href="#f2-ijo-42-03-0873" class="linksColor">Fig. 2</a>). When
expressions of Zyxin family members such as LPP and TRIP-6 were
examined in OSCC cell lines, there were no differences between
epithelial and fibroblastic type OSCC cell lines, and all cell
lines showed similar expression. These expression patterns
suggested that Zyxin family members did not compensate for each
other. These results indicated that expression of Zyxin was
suppressed in E-cadherin-expressing epithelial cell lines, while
N-cadherin-expressing cell lines strongly expressed Zyxin.</p><div id="f1-ijo-42-03-0873"><a class="fancybox" data-fancybox-group="figures" href="/article_images/ijo/42/3/IJO-42-03-0873-g00.jpg" title="Figure 1 - Phase contrast photographs of&#xA;representative OSCC cell lines that showed epithelial or&#xA;fibroblastic type morphology. Scale bars, 40 μm."><div class="panel"><table><tbody><tr><td width="115px"><img class="panel-image" src="/article_images/ijo/42/3/IJO-42-03-0873-g00.jpg"></img></td><td><h4>Figure 1</h4><p class="bold">Phase contrast photographs of
representative OSCC cell lines that showed epithelial or
fibroblastic type morphology. Scale bars, 40 μm.</p></td></tr></tbody></table></div></a></div><div id="f2-ijo-42-03-0873"><a class="fancybox" data-fancybox-group="figures" href="/article_images/ijo/42/3/IJO-42-03-0873-g01.jpg" title="Figure 2 - Results of western blot analysis of&#xA;eight OSCC cell lines, showing expression of EMT markers and Zyxin&#xA;family members. Decreased expression of E-cadherin and increased&#xA;expressions of N-cadherin and Zyxin was found in parallel to&#xA;morphological changes from epithelial type to fibroblastic type.&#xA;Lipoma preferred partner (LPP) and thyroid receptor-interacting&#xA;protein 6 (TRIP-6) are human Zyxin family members."><div class="panel"><table><tbody><tr><td width="115px"><img class="panel-image" src="/article_images/ijo/42/3/IJO-42-03-0873-g01.jpg"></img></td><td><h4>Figure 2</h4><p class="bold">Results of western blot analysis of
eight OSCC cell lines, showing expression of EMT markers and Zyxin
family members. Decreased expression of E-cadherin and increased
expressions of N-cadherin and Zyxin was found in parallel to
morphological changes from epithelial type to fibroblastic type.
Lipoma preferred partner (LPP) and thyroid receptor-interacting
protein 6 (TRIP-6) are human Zyxin family members.</p></td></tr></tbody></table></div></a></div>


<h5>Morphological changes of HOC-313 induced
by treatment with Zyxin siRNA</h5>
<p>Next, we examined the cellular localization of Zyxin
in HOC-313, a fibroblastic type OSCC cell line maintaining an
invasive character (<a href="#b28-ijo-42-03-0873" class="linksColor">28</a>).
Endogenous Zyxin was localized at adhesion plaques and some
overlapped with actin stress fibers in HOC-313 (<a href="#f3-ijo-42-03-0873" class="linksColor">Fig. 3A</a>). To clarify the function of Zyxin
in highly invasive cells, knockdown experiments of Zyxin by siRNA
were performed. On immunocytochemical analysis, a dramatic
reduction in Zyxin expression was observed in Zyxin siRNA-treated
cells as compared with control siRNA-treated cells (<a href="#f3-ijo-42-03-0873" class="linksColor">Fig. 3A</a>). On western blot analysis, the
protein level of Zyxin was also reduced in Zyxin siRNA-treated
cells (<a href="#f3-ijo-42-03-0873" class="linksColor">Fig. 3C</a>). These data
indicated that Zyxin siRNA specifically targeted Zyxin expression.
Moreover, Zyxin siRNA-treated HOC-313 showed morphological changes
(<a href="#f3-ijo-42-03-0873" class="linksColor">Fig. 3B</a>). Zyxin siRNA-treated
HOC-313 showed tripolar or polygonal shape and a large projected
cell area as compared with control siRNA-treated HOC-313.
Therefore, Zyxin was suggested to play important roles in
maintenance of cell morphology via actin re-arrangement. When
expression of Zyxin family members including LPP and TRIP-6 in
HOC-313 were examined after Zyxin siRNA treatment, their expression
was found to be uninhibited by such treatment (<a href="#f3-ijo-42-03-0873" class="linksColor">Fig. 3C</a>).</p><div id="f3-ijo-42-03-0873"><a class="fancybox" data-fancybox-group="figures" href="/article_images/ijo/42/3/IJO-42-03-0873-g02.jpg" title="Figure 3 - (A and B) Immunocytochemical analysis&#xA;of cell morphological changes induced by Zyxin siRNA treatment.&#xA;Blue, nuclear (DAPI); red, actin (phalloidin); green, Zyxin (FITC).&#xA;Note that Zyxin was localized at adhesion plaques and some&#xA;overlapped with actin stress fibers (arrow). Treatment with Zyxin&#xA;siRNA resulted in reduced expression of Zyxin and morphological&#xA;changes from spindle to polygonal shape. (C) Inhibition of Zyxin&#xA;expression by Zyxin siRNA treatment did not alter LPP or TRIP-6&#xA;expression."><div class="panel"><table><tbody><tr><td width="115px"><img class="panel-image" src="/article_images/ijo/42/3/IJO-42-03-0873-g02.jpg"></img></td><td><h4>Figure 3</h4><p class="bold">(A and B) Immunocytochemical analysis
of cell morphological changes induced by Zyxin siRNA treatment.
Blue, nuclear (DAPI); red, actin (phalloidin); green, Zyxin (FITC).
Note that Zyxin was localized at adhesion plaques and some
overlapped with actin stress fibers (arrow). Treatment with Zyxin
siRNA resulted in reduced expression of Zyxin and morphological
changes from spindle to polygonal shape. (C) Inhibition of Zyxin
expression by Zyxin siRNA treatment did not alter LPP or TRIP-6
expression.</p></td></tr></tbody></table></div></a></div>


<h5>Inhibition of cell proliferation, cell
migration and invasive potential in OSCC cell lines with
fibroblastic type morphology after treatment with Zyxin siRNA</h5>
<p>Since we found high levels of Zyxin expression in
OSCC cell lines with fibroblastic type morphology as compared with
cell lines with epithelial type morphology, the effects of
knockdown of Zyxin on cell proliferation, migration, and invasive
potential were examined in fibroblastic type of OSCC. Growth curves
of HOC-313 and TSU treated with Zyxin siRNA and control siRNA are
shown in <a href="#f4-ijo-42-03-0873" class="linksColor">Fig. 4</a>. Cell
proliferation was significantly inhibited in Zyxin siRNA-treated
HOC-313 and TSU from day 4 onward, and the reduction rate on day 4
was 53.5 and 35.2%, respectively. Significant difference was
observed only on day 2 in TSU. However, cell proliferation of SCCKN
and HSC-2 lines that do not express Zyxin, was not inhibited by
Zyxin siRNA treatment. Zyxin siRNA treatment of HOC-313 also
significantly inhibited cell migration and invasion. It inhibited
cell migration by 19.6% and cell invasion by 36.7% as compared with
control siRNA treatment (<a href="#f5-ijo-42-03-0873" class="linksColor">Fig. 5A and
B</a>). Zyxin siRNA treatment of TSU also significantly inhibited
cell migration by 20.9% and invasion by 65.7% as compared with
control siRNA treatment (<a href="#f5-ijo-42-03-0873" class="linksColor">Fig. 5C and
D</a>). To investigate why Zyxin siRNA treatment inhibited
proliferation of HOC-313, the apoptosis index and cell cycle
distribution were examined. However, the apoptosis index did not
increase, and the cell cycle distribution was unaffected by Zyxin
siRNA treatment (data not shown).</p><div id="f4-ijo-42-03-0873"><a class="fancybox" data-fancybox-group="figures" href="/article_images/ijo/42/3/IJO-42-03-0873-g03.jpg" title="Figure 4 - Inhibition of cell growth of&#xA;fibroblastic type OSCC cell lines HOC-313 and TSU by Zyxin siRNA&#xA;treatment. Cell growth did not differ until day 2 after Zyxin siRNA&#xA;treatment, but was significantly inhibited from day 4 onward as&#xA;compared with control siRNA treatment. Significant difference was&#xA;observed only on day 2 in TSU."><div class="panel"><table><tbody><tr><td width="115px"><img class="panel-image" src="/article_images/ijo/42/3/IJO-42-03-0873-g03.jpg"></img></td><td><h4>Figure 4</h4><p class="bold">Inhibition of cell growth of
fibroblastic type OSCC cell lines HOC-313 and TSU by Zyxin siRNA
treatment. Cell growth did not differ until day 2 after Zyxin siRNA
treatment, but was significantly inhibited from day 4 onward as
compared with control siRNA treatment. Significant difference was
observed only on day 2 in TSU.</p></td></tr></tbody></table></div></a></div><div id="f5-ijo-42-03-0873"><a class="fancybox" data-fancybox-group="figures" href="/article_images/ijo/42/3/IJO-42-03-0873-g04.jpg" title="Figure 5 - Inhibition of cell migration and&#xA;invasiveness of fibroblastic type OSCC cell lines HOC-313 and TSU&#xA;by Zyxin siRNA treatment. (A and C) Scratch assay: cell migration&#xA;was determined by measuring the distance from edge to edge after&#xA;6-h incubation. Zyxin siRNA inhibited cell migration significantly&#xA;as compared with control siRNA treatment. (B and D) Invasion assay:&#xA;cell invasion assay was performed using Matrigel invasion chambers.&#xA;HOC-313 and TSU cells were seeded and treated with Zyxin siRNA.&#xA;After 24-h incubation, cells invading through Matrigel-coated&#xA;membrane were counted. Zyxin siRNA significantly inhibited cell&#xA;invasion."><div class="panel"><table><tbody><tr><td width="115px"><img class="panel-image" src="/article_images/ijo/42/3/IJO-42-03-0873-g04.jpg"></img></td><td><h4>Figure 5</h4><p class="bold">Inhibition of cell migration and
invasiveness of fibroblastic type OSCC cell lines HOC-313 and TSU
by Zyxin siRNA treatment. (A and C) Scratch assay: cell migration
was determined by measuring the distance from edge to edge after
6-h incubation. Zyxin siRNA inhibited cell migration significantly
as compared with control siRNA treatment. (B and D) Invasion assay:
cell invasion assay was performed using Matrigel invasion chambers.
HOC-313 and TSU cells were seeded and treated with Zyxin siRNA.
After 24-h incubation, cells invading through Matrigel-coated
membrane were counted. Zyxin siRNA significantly inhibited cell
invasion.</p></td></tr></tbody></table></div></a></div>


<h5>Expression of Rho family proteins in
Zyxin siRNA-treated HOC-313 cells</h5>
<p>Because Rho family small GTPases such as RhoA, Rac1
and CDC42, are involved in cell migration and invasive potential,
as well as in regulation of EMT (<a href="#b29-ijo-42-03-0873" class="linksColor">29</a>), functional interactions between Rho
family and Zyxin were examined in HOC-313. Although there was no
significant difference in expression of RhoA between control siRNA-
and siZyxin-treated cells, expression of CDC42 and Rac1 was reduced
by 37.6 and 40.9%, respectively, on western blot analysis (<a href="#f6-ijo-42-03-0873" class="linksColor">Fig. 6</a>). Since it is well known that CDC42
mainly forms filopodia that act as sensors of the cancer
microenvironment and Rac1 forms lamellipodia that induce motogenic
activity and resolve extracellular matrix, the effect of the Rac1
inhibitor EHT1864 on expression of Zyxin in HOC-313 was examined.
When cells were treated with EHT1864, expression of Zyxin protein
was reduced slightly, but Zyxin mRNA decreased by half on real-time
PCR analysis (<a href="#f7-ijo-42-03-0873" class="linksColor">Fig. 7</a>). These
results indicated that interactions between Zyxin and Rac1 were one
of the factors related to migration and invasiveness of
fibroblastic type OSCC cells.</p><div id="f6-ijo-42-03-0873"><a class="fancybox" data-fancybox-group="figures" href="/article_images/ijo/42/3/IJO-42-03-0873-g05.jpg" title="Figure 6 - Analysis of Rho family proteins by&#xA;western blotting. Rho family small GTPases involved in cell&#xA;migration and invasion, such as RhoA, Rac1 and CDC42, were&#xA;examined. There was no significant difference in expression of&#xA;RhoA, but expressions of Rac1 and CDC42 were slightly reduced in&#xA;Zyxin siRNA-treated cells."><div class="panel"><table><tbody><tr><td width="115px"><img class="panel-image" src="/article_images/ijo/42/3/IJO-42-03-0873-g05.jpg"></img></td><td><h4>Figure 6</h4><p class="bold">Analysis of Rho family proteins by
western blotting. Rho family small GTPases involved in cell
migration and invasion, such as RhoA, Rac1 and CDC42, were
examined. There was no significant difference in expression of
RhoA, but expressions of Rac1 and CDC42 were slightly reduced in
Zyxin siRNA-treated cells.</p></td></tr></tbody></table></div></a></div><div id="f7-ijo-42-03-0873"><a class="fancybox" data-fancybox-group="figures" href="/article_images/ijo/42/3/IJO-42-03-0873-g06.jpg" title="Figure 7 - Effect of Rac1 inhibitor on&#xA;expression of Zyxin in HOC-313. Cells were treated with 50 nM of&#xA;Rac-1 inhibitor, EHT1864, for 4 h. Western blot analysis and&#xA;real-time PCR analysis of Zyxin protein and mRNA in HOC-313 cells&#xA;were performed. Expression of Zyxin in HOC-313 was partially&#xA;inhibited by Rac1 inhibitor."><div class="panel"><table><tbody><tr><td width="115px"><img class="panel-image" src="/article_images/ijo/42/3/IJO-42-03-0873-g06.jpg"></img></td><td><h4>Figure 7</h4><p class="bold">Effect of Rac1 inhibitor on
expression of Zyxin in HOC-313. Cells were treated with 50 nM of
Rac-1 inhibitor, EHT1864, for 4 h. Western blot analysis and
real-time PCR analysis of Zyxin protein and mRNA in HOC-313 cells
were performed. Expression of Zyxin in HOC-313 was partially
inhibited by Rac1 inhibitor.</p></td></tr></tbody></table></div></a></div>



<h4>Discussion</h4>
<p>An important hallmark of metastasis is increased
cell motility accompanied by actin cytoskeletal re-arrangement. To
gain insight into the relation between tumor cell morphology and
motility in OSCC, we analyzed the roles of Zyxin in cell motility
and cell morphology, using eight OSCC cell lines with different
morphological phenotypes. We found loss of E-cadherin expression
and increased N-cadherin expression on transition from epithelial
type to fibroblastic type. Reduced E-cadherin expression in OSCC
cells is associated with more aggressive tumor behavior and worse
outcomes (<a href="#b30-ijo-42-03-0873" class="linksColor">30</a>,<a href="#b31-ijo-42-03-0873" class="linksColor">31</a>). Moreover, cadherin switching (i.e.,
the loss of E-cadherin expression and gain of N-cadherin
expression) is a crucial event of EMT in human cancers, which
correlates with histologic differentiation, invasion pattern and
lymph node metastasis. Head and neck cancer cells also show
cadherin switching associated with EMT features and EMT cancer
cells show increased invasiveness (<a href="#b32-ijo-42-03-0873" class="linksColor">32</a>). However, molecular relations among
cell morphology, cell motility and EMT in OSCC cells are
incompletely understood.</p>
<p>Zyxin, a focal adhesion-associated LIM protein
family, harbors distinct actin polymerization activity (<a href="#b33-ijo-42-03-0873" class="linksColor">33</a>) and is located primarily at focal
adhesions and regulates actin cytoskeleton dynamics, cell movement,
and signal transduction (<a href="#b34-ijo-42-03-0873" class="linksColor">34</a>,<a href="#b35-ijo-42-03-0873" class="linksColor">35</a>).
When we reduced Zyxin expression levels in fibroblastic type OSCC
cells by treatment with Zyxin siRNA, cell growth was inhibited
significantly as compared with control siRNA-treated cells. To
clarify why Zyxin siRNA treatment inhibited the growth of
fibroblastic type OSCC cells, cell cycles and apoptosis induction
were examined. However, cell cycles were unaffected, and the
apoptosis index was not increased by Zyxin siRNA treatment. We
therefore speculated that the involvement of cell growth factor was
decreased by nutrient availability, hypoxia, heat shock, DNA damage
and osmotic stress (<a href="#b36-ijo-42-03-0873" class="linksColor">36</a>).</p>
<p>Cells with inhibited Zyxin expression display
reduced adhesive properties, reduced migration, reduced capacity to
build robust actin stress fibers in response to a chemical
stimulus, and disturbed focal adhesion accumulation of actin
regulators in the Zyxin family. Shinto <span class="italic">et al</span>(<a href="#b37-ijo-42-03-0873" class="linksColor">37</a>) reported that stable expression of
the oncoprotein associated with scirrhous gastric cancer cells
resulted in decreased Zyxin levels and a corresponding increase in
motility. Furthermore, Amsellem <span class="italic">et al</span>(<a href="#b38-ijo-42-03-0873" class="linksColor">38</a>) reported that knockout of Zyxin in
Ewing’s sarcoma cells is associated with enhanced cell motility.
However, knockdown of Zyxin by siRNA in SKOV-3 cells, a human
ovarian cancer cell line, had no influence on cell migration
(<a href="#b39-ijo-42-03-0873" class="linksColor">39</a>). To date, these disparate
effects have not been fully elucidated, but may result from
specific cellular features.</p>
<p>When Rho family protein expression was examined in
Zyxin knockdown cells, reduced expression of Rac1 and CDC42 was
found. This finding was consistent with the results of Pratt <span class="italic">et
al</span>(<a href="#b40-ijo-42-03-0873" class="linksColor">40</a>), who suggested that
the Ajuba/Zyxin family of LIM proteins leads to activation of Rac
during cell migration. These results suggest that Zyxin is a
potential EMT marker and that overexpression of Zyxin promotes cell
growth and invasion via up-regulation of Rac1, CDC42 or both in
OSCC cells. Although we have not yet found an inhibitor of CDC42,
EHT1864 decreased Zyxin mRNA and protein in HOC-313. Our results
suggest a mechanism by which reduced Zyxin expression might
contribute to tumor regression by affecting cytoarchitecture and
motility.</p>



<a class="linksColor">
</a>

<a class="linksColor">
</a>
<h4>Abbreviations:</h4><table xmlns="http://www.w3.org/1999/xhtml" class="def-list"><tr id="d7e516"><td class="def-term" id="d7e517" rowspan="1" colspan="1">
<p>OSCC</p>
</td><td valign="def-def" id="d7e519" rowspan="1" colspan="1">
<p class="first" id="d7e520">oral squamous cell carcinoma</p>
</td></tr><tr id="d7e522"><td class="def-term" id="d7e523" rowspan="1" colspan="1">
<p>LPP</p>
</td><td valign="def-def" id="d7e525" rowspan="1" colspan="1">
<p class="first" id="d7e526">lipoma preferred partner</p>
</td></tr><tr id="d7e528"><td class="def-term" id="d7e529" rowspan="1" colspan="1">
<p>TRIP6</p>
</td><td valign="def-def" id="d7e531" rowspan="1" colspan="1">
<p class="first" id="d7e532">thyroid receptor-interacting protein
6</p>
</td></tr></table>


<a class="linksColor">
</a>
<h4>Acknowledgements</h4>
<p>This study was supported by JSPS
KAKENHI Grant no. 22592249 (to K.N.) and Grant-in-Aid for Young
Scientists (B) 23792399 (to E.S.).</p>

<a class="linksColor">
</a>
<a class="linksColor">
</a>
<h4>References</h4>
<table xmlns="http://www.w3.org/1999/xhtml" class="ref-list"><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">1</span> <a name="b1-ijo-42-03-0873" id="b1-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e543" id="d7e543" shape="rect">
<!-- named anchor --></a>Pereira MC, Oliveira DT, Landman G and
Kowalski LP: Histologic subtypes of oral squamous cell carcinoma:
prognostic relevance. J Can Dent Assoc. 73:339–344. 2007.<a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/17484800" id="d7e545" name="d7e545" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">2</span> <a name="b2-ijo-42-03-0873" id="b2-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e550" id="d7e550" shape="rect">
<!-- named anchor --></a>Sudbo J, Bryne M, Mao L, Lotan R, et al:
Molecular based treatment of oral cancer. Oral Oncol. 39:749–758.
2003. <a target="xrefwindow" href="http://dx.doi.org/10.1016/S1368-8375(03)00098-8" id="d7e552" name="d7e552" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Molecular%20based%20treatment%20of%20oral%20cancer" id="d7e555" name="d7e555" shape="rect">Google Scholar</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">3</span> <a name="b3-ijo-42-03-0873" id="b3-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e560" id="d7e560" shape="rect">
<!-- named anchor --></a>Leemans CR, Tiwari R, Nauta JJ, van der
Waal I and Snow GB: Regional lymph node involvement and
significance in the development of distant metastases in head and
neck carcinoma. Cancer. 71:452–456. 1993. <a target="xrefwindow" href="http://dx.doi.org/10.1002/1097-0142(19930115)71:2%3C452::AID-CNCR2820710228%3E3.0.CO;2-B" id="d7e562" name="d7e562" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Regional%20lymph%20node%20involvement%20and%20significance%20in%20the%20development%20of%20distant%20metastases%20in%20head%20and%20neck%20carcinoma" id="d7e565" name="d7e565" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/8422638" id="d7e568" name="d7e568" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">4</span> <a name="b4-ijo-42-03-0873" id="b4-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e573" id="d7e573" shape="rect">
<!-- named anchor --></a>Leemans CR, Tiwari R, Nauta JJ, van der
Waal I and Snow GB: Recurrence at the primary site in head and neck
cancer and the significance of neck lymph node metastases as a
prognostic factor. Cancer. 73:187–190. 1994. <a target="xrefwindow" href="http://dx.doi.org/10.1002/1097-0142(19940101)73:1%3C187::AID-CNCR2820730132%3E3.0.CO;2-J" id="d7e575" name="d7e575" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Recurrence%20at%20the%20primary%20site%20in%20head%20and%20neck%20cancer%20and%20the%20significance%20of%20neck%20lymph%20node%20metastases%20as%20a%20prognostic%20factor" id="d7e578" name="d7e578" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/8275423" id="d7e581" name="d7e581" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">5</span> <a name="b5-ijo-42-03-0873" id="b5-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e586" id="d7e586" shape="rect">
<!-- named anchor --></a>Brattain MG, Willson J, Koterba A, Patil S
and Venkateswarlu S: Colorectal cancer. Human Cell Culture. Cancer
Cell Lines, Part 2. Masters JR and Palsson B: 2. Kluwer Academic
Publishers; Norwell, MA: pp. 293–304. 2002</p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">6</span> <a name="b6-ijo-42-03-0873" id="b6-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e591" id="d7e591" shape="rect">
<!-- named anchor --></a>Kozlowski J and Sensibar JA: Prostate
cancer. Human Cell Culture. Cancer Cell Lines, Part 2. Masters JR
and Palsson B: 2. Kluwer Academic Publishers; Norwell, MA: pp.
305–332. 2002</p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">7</span> <a name="b7-ijo-42-03-0873" id="b7-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e596" id="d7e596" shape="rect">
<!-- named anchor --></a>Sutherland R, Watts CK, Lee CS and
Musgrove EA: Breast cancer. Human Cell Culture. Cancer Cell Lines,
Part 2. Masters JR and Palsson B: 2. Kluwer Academic Publishers;
Norwell, MA: pp. 79–106. 2002</p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">8</span> <a name="b8-ijo-42-03-0873" id="b8-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e601" id="d7e601" shape="rect">
<!-- named anchor --></a>Yokoyama K, Kamata N, Hayashi E, Hoteiya
T, Ueda N, Fujimoto R and Nagayama M: Reverse correlation of
E-cadherin and snail expression in oral squamous cell carcinoma
cells in vitro. Oral Oncol. 37:65–71. 2001. <a target="xrefwindow" href="http://dx.doi.org/10.1016/S1368-8375(00)00059-2" id="d7e603" name="d7e603" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Reverse%20correlation%20of%20E-cadherin%20and%20snail%20expression%20in%20oral%20squamous%20cell%20carcinoma%20cells%20in%20vitro" id="d7e606" name="d7e606" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/11120485" id="d7e609" name="d7e609" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">9</span> <a name="b9-ijo-42-03-0873" id="b9-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e614" id="d7e614" shape="rect">
<!-- named anchor --></a>Frixen UH, Behrens J, Sachs M, et al:
E-cadherin-mediated cell-cell adhesion prevents invasiveness of
human carcinoma cells. J Cell Biol. 113:173–185. 1991. <a target="xrefwindow" href="http://dx.doi.org/10.1083/jcb.113.1.173" id="d7e616" name="d7e616" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=E-cadherin-mediated%20cell-cell%20adhesion%20prevents%20invasiveness%20of%20human%20carcinoma%20cells" id="d7e619" name="d7e619" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/2007622" id="d7e622" name="d7e622" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">10</span> <a name="b10-ijo-42-03-0873" id="b10-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e627" id="d7e627" shape="rect">
<!-- named anchor --></a>Petit MM, Fradelizi J, Golsteyn RM, et al:
LPP, an actin cytoskeleton protein related to zyxin, harbors a
nuclear export signal and transcriptional activation capacity. Mol
Biol Cell. 11:117–129. 2000. <a target="xrefwindow" href="http://dx.doi.org/10.1091/mbc.11.1.117" id="d7e629" name="d7e629" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=LPP,%20an%20actin%20cytoskeleton%20protein%20related%20to%20zyxin,%20harbors%20a%20nuclear%20export%20signal%20and%20transcriptional%20activation%20capacity" id="d7e632" name="d7e632" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/10637295" id="d7e635" name="d7e635" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">11</span> <a name="b11-ijo-42-03-0873" id="b11-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e641" id="d7e641" shape="rect">
<!-- named anchor --></a>Yi J and Beckerle MC: The human TRIP6 gene
encodes a LIM domain protein and maps to chromosome 7q22, a region
associated with tumorigenesis. Genomics. 49:314–316. 1998.
<a target="xrefwindow" href="http://dx.doi.org/10.1006/geno.1998.5248" id="d7e643" name="d7e643" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=The%20human%20TRIP6%20gene%20encodes%20a%20LIM%20domain%20protein%20and%20maps%20to%20chromosome%207q22,%20a%20region%20associated%20with%20tumorigenesis" id="d7e646" name="d7e646" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/9598321" id="d7e649" name="d7e649" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">12</span> <a name="b12-ijo-42-03-0873" id="b12-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e654" id="d7e654" shape="rect">
<!-- named anchor --></a>Grunewald TG, Kammerer U, Schulze E,
Schindler D, Hong A, Zimmer M and Butt E: Silencing of LASP-1
influences zyxin localization, inhibits proliferation and reduces
migration in breast cancer cells. Exp Cell Res. 312:974–982. 2006.
<a target="xrefwindow" href="http://dx.doi.org/10.1016/j.yexcr.2005.12.016" id="d7e656" name="d7e656" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Silencing%20of%20LASP-1%20influences%20zyxin%20localization,%20inhibits%20proliferation%20and%20reduces%20migration%20in%20breast%20cancer%20cells" id="d7e659" name="d7e659" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/16430883" id="d7e662" name="d7e662" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">13</span> <a name="b13-ijo-42-03-0873" id="b13-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e667" id="d7e667" shape="rect">
<!-- named anchor --></a>Grunewald TG, Kammerer U, Winkler C,
Schindler D, Sickmann A, Honig A and Butt E: Overexpression of
LASP-1 mediates migration and proliferation of human ovarian cancer
cells and influences zyxin localisation. Br J Cancer. 96:296–305.
2007. <a target="xrefwindow" href="http://dx.doi.org/10.1038/sj.bjc.6603545" id="d7e669" name="d7e669" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Overexpression%20of%20LASP-1%20mediates%20migration%20and%20proliferation%20of%20human%20ovarian%20cancer%20cells%20and%20influences%20zyxin%20localisation" id="d7e672" name="d7e672" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/17211471" id="d7e675" name="d7e675" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">14</span> <a name="b14-ijo-42-03-0873" id="b14-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e680" id="d7e680" shape="rect">
<!-- named anchor --></a>Hervy M, Hoffman L and Beckerle MC: From
the membrane to the nucleus and back again: bifunctional focal
adhesion proteins. Curr Opin Cell Biol. 18:524–532. 2006.
<a target="xrefwindow" href="http://dx.doi.org/10.1016/j.ceb.2006.08.006" id="d7e682" name="d7e682" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=From%20the%20membrane%20to%20the%20nucleus%20and%20back%20again:%20bifunctional%20focal%20adhesion%20proteins" id="d7e685" name="d7e685" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/16908128" id="d7e688" name="d7e688" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">15</span> <a name="b15-ijo-42-03-0873" id="b15-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e693" id="d7e693" shape="rect">
<!-- named anchor --></a>Nix DA and Beckerle MC:
Nuclear-cytoplasmic shuttling of the focal contact protein, zyxin:
a potential mechanism for communication between sites of cell
adhesion and the nucleus. J Cell Biol. 138:1139–1147. 1997.
<a target="xrefwindow" href="http://dx.doi.org/10.1083/jcb.138.5.1139" id="d7e695" name="d7e695" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Nuclear-cytoplasmic%20shuttling%20of%20the%20focal%20contact%20protein,%20zyxin:%20a%20potential%20mechanism%20for%20communication%20between%20sites%20of%20cell%20adhesion%20and%20the%20nucleus" id="d7e698" name="d7e698" shape="rect">Google Scholar</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">16</span> <a name="b16-ijo-42-03-0873" id="b16-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e703" id="d7e703" shape="rect">
<!-- named anchor --></a>Nix DA, Fradelizi J, Bockholt S, Menichi
B, Louvard D, Friedich E and Beckerle MC: Targeting of zyxin to
sites of actin membrane interaction and to the nucleus. J Biol
Chem. 276:34759–34767. 2001. <a target="xrefwindow" href="http://dx.doi.org/10.1074/jbc.M102820200" id="d7e705" name="d7e705" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Targeting%20of%20zyxin%20to%20sites%20of%20actin%20membrane%20interaction%20and%20to%20the%20nucleus" id="d7e708" name="d7e708" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/11395501" id="d7e711" name="d7e711" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">17</span> <a name="b17-ijo-42-03-0873" id="b17-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e716" id="d7e716" shape="rect">
<!-- named anchor --></a>van der Gaag EJ, Leccica MT, Dekker SK,
Jalbert NL, Amodeo DM and Byers HR: Role of Zyxin in differential
cell spreading and proliferation of melanoma cells and melanocytes.
J Invest Dermatol. 118:246–254. 2002.<a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/11841540" id="d7e718" name="d7e718" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">18</span> <a name="b18-ijo-42-03-0873" id="b18-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e723" id="d7e723" shape="rect">
<!-- named anchor --></a>Sperry RB, Bishop SN, Bramwell JJ, et al:
Zyxin controls migration in epithelial-mesenchymal transition by
mediating actin-membrane linkages at cell-cell junctions. J Cell
Physiol. 222:612–624. 2010.<a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/19927303" id="d7e725" name="d7e725" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">19</span> <a name="b19-ijo-42-03-0873" id="b19-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e730" id="d7e730" shape="rect">
<!-- named anchor --></a>Urade M, Sugi M and Miyazaki T:
Establishment of three bleomycin-resistant human carcinoma cell
lines and their cross resistance to other antitumor agents. Cancer.
61:1501–1507. 1998. <a target="xrefwindow" href="http://dx.doi.org/10.1002/1097-0142(19880415)61:8%3C1501::AID-CNCR2820610805%3E3.0.CO;2-4" id="d7e732" name="d7e732" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Establishment%20of%20three%20bleomycin-resistant%20human%20carcinoma%20cell%20lines%20and%20their%20cross%20resistance%20to%20other%20antitumor%20agents" id="d7e735" name="d7e735" shape="rect">Google Scholar</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">20</span> <a name="b20-ijo-42-03-0873" id="b20-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e740" id="d7e740" shape="rect">
<!-- named anchor --></a>Kamata N, Chida K, Rikimaru K, Horikoshi
M, Enomoto S and Kuroki T: Growth inhibitory effects of epidermal
growth factor and overexpression of its receptors on human squamous
cell carcinomas in culture. Cancer Res. 46:1648–1653.
1986.<a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/3004701" id="d7e742" name="d7e742" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">21</span> <a name="b21-ijo-42-03-0873" id="b21-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e747" id="d7e747" shape="rect">
<!-- named anchor --></a>Kawahara E, Okada Y, Nakanishi I, Iwata K,
Kojima S, Kumagai S and Yamamoto E: The expression of invasive
behavior of differentiated squamous carcinoma cell line evaluated
by an in vitro invasion model. Jpn J Cancer Res. 84:409–418. 1993.
<a target="xrefwindow" href="http://dx.doi.org/10.1111/j.1349-7006.1993.tb00151.x" id="d7e749" name="d7e749" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=The%20expression%20of%20invasive%20behavior%20of%20differentiated%20squamous%20carcinoma%20cell%20line%20evaluated%20by%20an%20in%20vitro%20invasion%20model" id="d7e752" name="d7e752" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/8514607" id="d7e755" name="d7e755" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">22</span> <a name="b22-ijo-42-03-0873" id="b22-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e761" id="d7e761" shape="rect">
<!-- named anchor --></a>Kojima S: Experimenral study of invasive
activity of oral squamous cell carcinoma. J Juzen Med Soc.
101:266–281. 1992.</p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">23</span> <a name="b23-ijo-42-03-0873" id="b23-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e766" id="d7e766" shape="rect">
<!-- named anchor --></a>Hoteiya T, Hayashi E, Satomura K, Kamata N
and Nagayama N: Expression of E-cadherin in oral cancer cell lines
and its relationship to invasiveness in SCID mice in vivo. J Oral
Pathol Med. 28:107–111. 1999. <a target="xrefwindow" href="http://dx.doi.org/10.1111/j.1600-0714.1999.tb02006.x" id="d7e768" name="d7e768" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Expression%20of%20E-cadherin%20in%20oral%20cancer%20cell%20lines%20and%20its%20relationship%20to%20invasiveness%20in%20SCID%20mice%20in%20vivo" id="d7e771" name="d7e771" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/10069537" id="d7e774" name="d7e774" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">24</span> <a name="b24-ijo-42-03-0873" id="b24-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e779" id="d7e779" shape="rect">
<!-- named anchor --></a>Kawashiri S, Tanaka A, Noguchi N, et al:
Invasion and metastasis models of oral squamous carcinoma cell
lines. Jpn J Tissue Cult Dent Res. 12:1–13. 2004.(in Japanese).</p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">25</span> <a name="b25-ijo-42-03-0873" id="b25-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e784" id="d7e784" shape="rect">
<!-- named anchor --></a>Moriyama M: Development of diffuse
invasive (grade4D) human oral squamous cell carcinoma model in
severe combined immunodeficiency mice: microangioarchitectual
analysis and immunohistochemical study. Oral Oncol. 35:395–400.
1999. <a target="xrefwindow" href="http://dx.doi.org/10.1016/S1368-8375(99)00009-3" id="d7e786" name="d7e786" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Development%20of%20diffuse%20invasive%20(grade4D)%20human%20oral%20squamous%20cell%20carcinoma%20model%20in%20severe%20combined%20immunodeficiency%20mice:%20microangioarchitectual%20analysis%20and%20immunohistochemical%20study" id="d7e789" name="d7e789" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/10645405" id="d7e792" name="d7e792" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">26</span> <a name="b26-ijo-42-03-0873" id="b26-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e797" id="d7e797" shape="rect">
<!-- named anchor --></a>Hashitani S, Urade M, Nishimura N, Maeda
N, Takaoka K, Noguchi K and Sakurai K: Apoptosis induction
enhancement of anticancer drugs by celecoxib, a selective
cyclooxygenase-2 inhibitor, in human head neck carcinoma cell
lines. Int J Oncol. 23:665–672. 2003.</p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">27</span> <a name="b27-ijo-42-03-0873" id="b27-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e802" id="d7e802" shape="rect">
<!-- named anchor --></a>Hiromoto T, Noguchi K, Yamamura M, et al:
Up-regulation of neurophil gelatinase-associated lipocalin in oral
squaamous cell carcinoma: relation to cell differentiation. Oncol
Rep. 26:1415–1421. 2011.<a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/21874256" id="d7e804" name="d7e804" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">28</span> <a name="b28-ijo-42-03-0873" id="b28-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e809" id="d7e809" shape="rect">
<!-- named anchor --></a>Higashikawa K, Yoneda S, Tobiume K, et al:
ΔNp63α-dependent expression of Id-3 distinctively suppresses the
invasiveness of human squamous cell carcinoma. Int J Cancer.
124:2837–2844. 2009.</p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">29</span> <a name="b29-ijo-42-03-0873" id="b29-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e814" id="d7e814" shape="rect">
<!-- named anchor --></a>Bendris N, Arsic N, Lemmers B and
Bianchard JM: Cyclin A2, Rho GTPases and EMT. Small GTPases. Oct
1–2012.(Epub ahead of print).</p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">30</span> <a name="b30-ijo-42-03-0873" id="b30-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e819" id="d7e819" shape="rect">
<!-- named anchor --></a>Diniz-Freitas M, García-Caballero T,
Antúnez-López J, Gándara-Rey JM and García-García A: Reduced
E-cadherin expression is an indicator of unfavourable prognosis in
oral squamous cell carcinoma. Oral Oncol. 42:190–200. 2006.
<a target="xrefwindow" href="http://dx.doi.org/10.1016/j.oraloncology.2005.07.010" id="d7e821" name="d7e821" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Reduced%20E-cadherin%20expression%20is%20an%20indicator%20of%20unfavourable%20prognosis%20in%20oral%20squamous%20cell%20carcinoma" id="d7e824" name="d7e824" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/16249116" id="d7e827" name="d7e827" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">31</span> <a name="b31-ijo-42-03-0873" id="b31-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e832" id="d7e832" shape="rect">
<!-- named anchor --></a>Tanaka N, Odajima T, Ogi K, Ikeda T and
Satoh M: Expression of E-cadherin, alpha-catenin, and beta-catenin
in the process of lymph node metastasis in oral squamous cell
carcinoma. Br J Cancer. 89:557–563. 2003. <a target="xrefwindow" href="http://dx.doi.org/10.1038/sj.bjc.6601124" id="d7e834" name="d7e834" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Expression%20of%20E-cadherin,%20alpha-catenin,%20and%20beta-catenin%20in%20the%20process%20of%20lymph%20node%20metastasis%20in%20oral%20squamous%20cell%20carcinoma" id="d7e837" name="d7e837" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/12888830" id="d7e840" name="d7e840" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">32</span> <a name="b32-ijo-42-03-0873" id="b32-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e845" id="d7e845" shape="rect">
<!-- named anchor --></a>Krisanaprakornkit S and Iamaroon A:
Epithelial-mesenchymal transition in oral squamous cell carcinoma.
ISRN Oncol. 681469. 2012. <a target="xrefwindow" href="http://dx.doi.org/10.5402/2012/681469" id="d7e847" name="d7e847" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Epithelial-mesenchymal%20transition%20in%20oral%20squamous%20cell%20carcinoma" id="d7e850" name="d7e850" shape="rect">Google Scholar</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">33</span> <a name="b33-ijo-42-03-0873" id="b33-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e856" id="d7e856" shape="rect">
<!-- named anchor --></a>Fradelizi j, Noireaux V, Plastino J, et
al: ActA and human zyxin harbor Arp2/3-independent
actin-polymerization activity. Nat Cell Biol. 3:699–707. 2001.
<a target="xrefwindow" href="http://dx.doi.org/10.1038/35087009" id="d7e858" name="d7e858" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=ActA%20and%20human%20zyxin%20harbor%20Arp2/3-independent%20actin-polymerization%20activity" id="d7e861" name="d7e861" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/11483954" id="d7e864" name="d7e864" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">34</span> <a name="b34-ijo-42-03-0873" id="b34-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e869" id="d7e869" shape="rect">
<!-- named anchor --></a>Beckerle MC: Spatial control of action
filament assembly: lessons from Listeria. Cell. 95:741–748. 1998.
<a target="xrefwindow" href="http://dx.doi.org/10.1016/S0092-8674(00)81697-9" id="d7e871" name="d7e871" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Spatial%20control%20of%20action%20filament%20assembly:%20lessons%20from%20Listeria" id="d7e874" name="d7e874" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/9865692" id="d7e877" name="d7e877" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">35</span> <a name="b35-ijo-42-03-0873" id="b35-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e882" id="d7e882" shape="rect">
<!-- named anchor --></a>Kadrmas JL and Beckerle MC: The LIM
domain: from the cytoskeleton to the nucleus. Nat Rev Mol Cell
Biol. 5:920–931. 2004. <a target="xrefwindow" href="http://dx.doi.org/10.1038/nrm1499" id="d7e884" name="d7e884" shape="rect">View
Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=The%20LIM%20domain:%20from%20the%20cytoskeleton%20to%20the%20nucleus" id="d7e887" name="d7e887" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/15520811" id="d7e890" name="d7e890" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">36</span> <a name="b36-ijo-42-03-0873" id="b36-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e895" id="d7e895" shape="rect">
<!-- named anchor --></a>Reiling JH and Sabatini DM: Stress and
mTORture signaling. Oncogene. 25:6373–6383. 2006. <a target="xrefwindow" href="http://dx.doi.org/10.1038/sj.onc.1209889" id="d7e897" name="d7e897" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Stress%20and%20mTORture%20signaling" id="d7e900" name="d7e900" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/17041623" id="d7e903" name="d7e903" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">37</span> <a name="b37-ijo-42-03-0873" id="b37-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e908" id="d7e908" shape="rect">
<!-- named anchor --></a>Shinto O, Yashiro M, Kawajiri H, Shimizu
K, Shimizu T, Miwa A and Hirakawa K: Inhibitory effect of a TGFbeta
receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous
gastric cancer cells. Br J Cancer. 102:844–851. 2010. <a target="xrefwindow" href="http://dx.doi.org/10.1038/sj.bjc.6605561" id="d7e910" name="d7e910" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Inhibitory%20effect%20of%20a%20TGFbeta%20receptor%20type-I%20inhibitor,%20Ki26894,%20on%20invasiveness%20of%20scirrhous%20gastric%20cancer%20cells" id="d7e913" name="d7e913" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/20145621" id="d7e916" name="d7e916" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">38</span> <a name="b38-ijo-42-03-0873" id="b38-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e921" id="d7e921" shape="rect">
<!-- named anchor --></a>Amsellem V, Kryszke MH, Hervy M, et al:
The actin cytoskeleton-associated protein zyxin acts as a tumor
suppressor in Ewing tumor cells. Exp Cell Res. 304:443–456. 2005.
<a target="xrefwindow" href="http://dx.doi.org/10.1016/j.yexcr.2004.10.035" id="d7e923" name="d7e923" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=The%20actin%20cytoskeleton-associated%20protein%20zyxin%20acts%20as%20a%20tumor%20suppressor%20in%20Ewing%20tumor%20cells" id="d7e926" name="d7e926" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/15748890" id="d7e929" name="d7e929" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">39</span> <a name="b39-ijo-42-03-0873" id="b39-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e934" id="d7e934" shape="rect">
<!-- named anchor --></a>Wendt MK, Allington TM and Schiemann WP:
Mechanisms of the epithelial-mesenchymal transition by TGF-beta.
Future Oncol. 5:1145–1168. 2009. <a target="xrefwindow" href="http://dx.doi.org/10.2217/fon.09.90" id="d7e936" name="d7e936" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Mechanisms%20of%20the%20epithelial-mesenchymal%20transition%20by%20TGF-beta" id="d7e939" name="d7e939" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/19852727" id="d7e942" name="d7e942" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">40</span> <a name="b40-ijo-42-03-0873" id="b40-ijo-42-03-0873" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e947" id="d7e947" shape="rect">
<!-- named anchor --></a>Pratt S J, Epple H, Ward M, Feng Y, Braga
VM and Longmore GD: The LIM protein Ajuba influences p130Cas
localization and Rac1 activity during cell migration. J Cell Biol.
168:813–824. 2005.<a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/15728191" id="d7e949" name="d7e949" shape="rect">PubMed/NCBI</a></p>
</td></tr></table>





</div>
						</div>

						<div>
						   
						</div>

						<div>
							
						</div>

						<div id="moreLikeThisDiv">
	
	<h4>Related Articles</h4>
	<ul style="list-style-type:disc" id="moreLikeThisUl" class="moreLikeThisClassFragment">
        
     </ul>
	          		
		
	</div>

						<div class="article_interactive">
							<ul class="article_icons">
								<li><a href="/10.3892/ijo.2013.1761/abstract"><img
										src="/resources/images/iconabstract.png" alt="Abstract" /></a></li>

								<li><a href="/10.3892/ijo.2013.1761?text=fulltext">
										<img src="/resources/images/iconarticle.png"
										title="View Full Article" />
								</a> </li>

								<li><a href="/10.3892/ijo.2013.1761/download"> <img
										src="/resources/images/icondownload.png"
										title="Download Article" />
								</a> </li>

							</ul>

							<!-- AddThis Button -->
							<ul
								class="article_sharing addthis_toolbox addthis_default_style addthis_32x32_style">

								

								

								

								<li><a
									class="at300b"
									href="https://twitter.com/intent/follow?screen_name=@IjOncology">
										<img src="/resources/images/twitter_32.png"
										alt="Twitter" />
								</a></li>

								

								

								

								
								<li><a class="addthis_button_facebook"></a></li>
								<li><a class="addthis_button_preferred_3"></a></li>
								<li><a class="addthis_button_preferred_4"></a></li>
								<li><a class="addthis_button_compact"></a></li>
							</ul>
						</div>
					</div>
				</div>

				<div class="journal_information">
					<!-- Duplicated from Journal to avoid caching issue if a fragment -->
					<div class="journal_details">
						<div>
							<img src="/ISSUE_IMAGES/ijo_42_3.jpg"
								alt="Journal Cover" />
						</div>
						
											
						
						<p class="bold">
							<span class="bold">March 2013</span> 
							<br/>
							<span>Volume 42 Issue 3</span>
						</p>
						<p>
							Print ISSN: <span>1019-6439</span><br />
							Online ISSN:<span>1791-2423</span><br />
						</p>

						<p>
							<a href="/myaccount/updateaccountdetails?etocUpdate=1">Sign
								up for eToc alerts</a>
						</p>

						<p>
							<a href="/var/library_recommendation_form.pdf">Recommend to
								Library</a>
						</p>
					</div>

					<div class="article_sidebar">
						<ul>
							<li class="sidebar_title">Article Options</li>
							<li class="sidebar_subtitle">Viewing Options</li>
							<li><a href="/10.3892/ijo.2013.1761/abstract">View
									Abstract</a></li>
							<li><a id="isFullTextVisible" href="/10.3892/ijo.2013.1761?text=fulltext">Full
									Text</a></li>
							<li><a id="downloadPDFURL" href="/10.3892/ijo.2013.1761/download">
									Download PDF </a> </li>


							<li>
								</li>

							<li class="sidebar_subtitle">Citations</li>
							<li><a href='#' class='osx'>Cite This Article</a></li>
							<li><a href="/downloadRisFile/10.3892/ijo.2013.1761">Download Citation</a></li>



							<li id="track_citation"><a href="/trackCitation/10.3892/ijo.2013.1761"
								title="If you would like to be notified via email each time this article is cited, please click on the link.">Create
									Citation Alert</a></li>
							<li id="remove_track_citation"><a href="/removeTrackCitation/10.3892/ijo.2013.1761"
								title="If you would like not to be notified via email each time this article is cited, please click on the link.">Remove
									Citation Alert</a></li>
							<li><a href="http://scholar.google.co.uk/scholar?hl=en&amp;q=related:http://www.spandidos-publications.com/10.3892/ijo.2013.1761">Cited
									By</a></li>
							<li class="sidebar_subtitle">Related Articles</li>
							<li><a href="#moreLikeThisDiv">on Spandidos Publications</a></li>
							<li class="sidebar_subtitle">Similar Articles</li>
							<li><a href="http://scholar.google.co.uk/scholar?hl=en&amp;q=related:http://www.spandidos-publications.com/10.3892/ijo.2013.1761">on
									Google Scholar</a></li>
							<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?cmd=Link&amp;db=pubmed&amp;dbFrom=PubMed&amp;from_uid=23585&amp;holding=f1000,f1000m,isrctn">on
									Pub Med</a></li>
							<li class="sidebar_subtitle">Copyright</li>
							<li><a href="http://www.copyright.com/openurl.do?issn=1791-2423">&copy;
									Get Permissions</a></li>
						</ul>

						<ul class="fixed_width_scopus">

							<li class="sidebar_title"><a href="/ijo">Journal Metrics</a></li>
							<li>Impact
								Factor: <span class="impact_factor_font">5.65</span>
							</li>

							<li>Ranked
								<span class="impact_factor_font"></span>

								<span>Oncology</span> <br /> (total
								number of cites)
							</li>

							<li>
								CiteScore: <span class="impact_factor_font">8.2</span> 
							</li>

							<li>CiteScore
								Rank: <span class="impact_factor_font">Q1: #52/340</span> <span>Oncology</span> 
							</li>

							<li>
								Source Normalized Impact per Paper (SNIP): <span
								class="impact_factor_font">1.045</span>
								
							</li>
							<li>
								SCImago Journal Rank (SJR): <span class="impact_factor_font">1.405</span> 
							</li>
						</ul>
					</div>






					<div class="article_sidebar twitter-articles">
						<div>
							<a class="twitter-timeline" data-width="25" data-tweet-limit="5"
								href="https://twitter.com/IjOncology?ref_src=twsrc%5Etfw">Tweets
								by @IjOncology</a>
						</div>
						<div class="article-twitter-buttons">
							<a href="https://twitter.com/IjOncology?ref_src=twsrc%5Etfw"
								class="twitter-follow-button" data-show-screen-name="false"
								data-dnt="true" data-show-count="false">Follow @IjOncology</a>

						</div>
					</div>


					

					


					


					

					

					


					

				</div>


			</div>

		</div>





		<div class="wide">
	
	<div class="event fixed_width">
			<a id="downloadCancerStoryPdf"  class="staticContent" href="#">
					<img src="/resources/images/cancer_story_banner.jpg" alt="The Cancer Story" />
			</a>
				
				
		</div>
	
		<div class="event fixed_width">
				<a href="http://www.worldacademyofsciences.com/rome2020.html" class="staticContent">
				<img src="/resources/images/1st_conference.jpg" alt="International Symposium on Molecular Medicine Conference Banner" />
				</a>				
		</div>
		
				
		<div class="event fixed_width">
				<a href="/pages/conference" class="staticContent">
				<img src="/resources/images/conferencebanner.jpg" alt="World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner" />
				</a>					
		</div>
		
		<div class="event fixed_width">
				<a href="http://www.worldacademyofsciences.com/china2020.html" class="staticContent">
				<img src="/resources/images/3rd_conference.jpg" alt="28th International Symposium on Molecular Medicine" />
				</a>				
		</div>
		
		<div class="event fixed_width">
				<a href="http://www.worldacademyofsciences.com/chile2020.html" class="staticContent">
				<img src="/resources/images/2nd_conference.jpg" alt="International Symposium on Molecular Medicine Conference Banner" />
				</a>				
		</div>	
		
		
		<div class="event fixed_width">
				<a href="http://www.worldacademyofsciences.com" class="staticContent">
				<img src="/resources/images/world_of_academy_banner.jpg" alt="World Academy Of Sciences Banner" />
				</a>				
		</div>
	
			
			
		
		
	</div>
		<div class="footer wide">
	    
		 <div id="navbar" align="center" class="fixed_width footer">
			 			 
		 <div class="gdpr_table" >
			<div class="gdpr_row">
				<div class="gdpr_cell_header">
					<p><strong>This site uses cookies</strong></p>
				</div>		
					
			</div>
			<div class="gdpr_row">
				<div class="gdpr_cell_text">
					<p>You can change your cookie settings at any time by following the instructions in our <a	href="https://www.spandidos-publications.com/pages/cookies"	target="_blank">Cookie Policy</a>. To find out more, you may read our
					<a	href="https://www.spandidos-publications.com/pages/privacy"	target="_blank">Privacy Policy</a>. 
					<a href="#"  id="gdprButton"	class="gdpr_button">I agree</a>	
					</p>
				</div>			
						
			</div>
		</div>
			  
		</div>


		<div class="footer fixed_width">
				<div class="footer_copyright">
						<p  id="rightsReserved">0 </p>
			</div>
			
			
			<div class="footer_links">
				<ul class="social">
					<li>
						<a href="https://twitter.com/intent/follow?screen_name=@SpandidosP">  <img src="/resources/images/twitter.png" alt="Twitter"/> </a>             
					</li>
					<li>
						<a href="http://www.linkedin.com/company/2926613" title="Follow us on LinkedIn"><img src="/resources/images/linkedin.png" alt="LinkedIn"/></a>
					</li>
					<li>
						<a href="https://www.facebook.com/SpandidosPublications" title="Likes us on Facebook"><img src="/resources/images/facebook.png" alt="Facebook"/></a>
					</li>
					
				</ul>
				<ul class="footer_nav">
					<li><a href="/pages/about" id="about" class="staticContent">About</a></li>
					<li>
						<a href="/pages/contact" id="Contact" class="staticContent">Contact</a>
					</li>
					<li><a href="/pages/help">Help</a></li>
					<li><a href="/pages/cookies">Cookie Policy</a></li>
					<li><a href="/pages/privacy">Privacy Policy</a></li>

				</ul>
			</div>
		</div>
		
		 
		<div id="growl" class="bottom-left"></div>
		
	<!--Add the following script at the bottom of the web page (before </body></html>)-->
<script type="text/javascript">function add_chatwidget(){var hccid=66058258;var nt=document.createElement("script");nt.async=true;nt.src="https://www.mylivechat.com/chatwidget.aspx?hccid="+hccid;var ct=document.getElementsByTagName("script")[0];ct.parentNode.insertBefore(nt,ct);}
add_chatwidget();</script>
		
		<script src="/resources/js/jquery-3.4.1.min.js" type="text/javascript"></script>
		<script src="/resources/js/jquery-migrate-3.1.0.min.js" type="text/javascript"></script>

		<script src="/resources/js/app.js" type="text/javascript"></script>
		<script src="/resources/js/js.cookie-2.2.0.min.js"></script>
		
		 <script>
  		  	/*<![CDATA[*/
  		  	  $(document).ready(function () {
  		  		  		  		
  		  		if(null){  		  			
  		  		
  		  			sessionStorage.setItem("orcid_logout_uri", null);
  		  		}
  	
  		  		$("#rightsReserved").html('Copyright &copy; Spandidos Publications ' +(new Date()).getFullYear()+'. All rights reserved.');
  		  	});
  		  		
			 /*]]>*/
   		 </script>
		
		<script type="text/javascript">
			(function(b, o, i, l, e, r) {
				b.GoogleAnalyticsObject = l;
				b[l] || (b[l] =
						function() {
							(b[l].q = b[l].q || []).push(arguments)
						});
				b[l].l = +new Date;
				e = o.createElement(i);
				r = o.getElementsByTagName(i)[0];
				e.src = '//www.google-analytics.com/analytics.js';
				r.parentNode.insertBefore(e, r)
			}(window, document, 'script', 'ga'));
			ga('create', 'UA-45385578-1');
			ga('send', 'pageview');
		</script>
			<script async="async" crossorigin="anonymous" src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
		<!-- Google Code for English -->
		<!-- Remarketing tags may not be associated with personally identifiable information or placed on pages related to sensitive categories. For instructions on adding this tag and more information on the above requirements, read the setup guide: google.com/ads/remarketingsetup -->
		<script type="text/javascript">
			/* <![CDATA[ */
			var google_conversion_id = 982681053;
			var google_conversion_label = "ewoHCKvwggoQ3YvK1AM";
			var google_custom_params = window.google_tag_params;
			var google_remarketing_only = true;
			/* ]]> */
		</script>
		<script type="text/javascript" src="//www.googleadservices.com/pagead/conversion.js">
		</script>
		
		<noscript>
			<div style="display:inline;">
				<img height="1" width="1" style="border-style:none;" alt="" src="//googleads.g.doubleclick.net/pagead/viewthroughconversion/982681053/?value=1.00&amp;label=ewoHCKvwggoQ3YvK1AM&amp;guid=ON&amp;script=0"/>
			</div>
		</noscript>
	<script>
    /*<![CDATA[*/
    	
    	$( "#gdprButton" ).click(function() {
    		Cookies.set('spandidos-gdpr', 'true', { expires: 365 });
   		 	$('#navbar').hide();
   		   $(window).scroll(function() {      		
         	 $('#navbar').hide();      		  
         	});
		});
		
		$('#logout').click(function() { 					
					
			forceSignOut();					
		});
    	
    	function forceSignOut(){
    		
    		let ocridlogouturl = sessionStorage.getItem("orcid_logout_uri");    		
    		ocridlogouturl = removeDoubleQuote(ocridlogouturl);    		
    		
    		$.ajax({
                url: ocridlogouturl,
                dataType: 'jsonp',
                success: function(result,status,xhr) {
                    console.log("Logged In: " + result.loggedIn);
                },
                error: function (xhr, status, error) {
                	console.log(status);
                }
            });
    	}
    	
    	function removeDoubleQuote(url){
    		return url.replace(/['"]+/g, '');
    	}
    
    	//Show guest editors list only if it has a person
        $(document).ready(function () {	
        	
	  		$( ".guestEditors" ).each(function() {
	  			
	  			if($(this).children().length > 0) {
		  			$(this).parent().show();
		  		}
	  		 
	  		});
	  	});
	/*]]>*/
	 </script>
		
	</div>

		<script type='text/javascript'
			src="/resources/js/jquery.simplemodal.js"></script>
		<script type='text/javascript' src="/resources/js/osx.js"></script>
		<!-- modal content -->
		<div id="osx-modal-content">
			<div id="osx-modal-title">Copy and paste a formatted citation</div>
			<div class="close">
				<a href="#" class="simplemodal-close">x</a>
			</div>
			<div id="osx-modal-data">
				<div class="inline">
					<div>
						<div class="citationFormat">Spandidos Publications style</div>
						<div class="citation">Yamamura M, Noguchi K, Nakano Y, Segawa E, Zushi Y, Takaoka K, Kishimoto H, Hashimoto-Tamaoki T and Urade M: Functional analysis of Zyxin in cell migration and invasive potential of oral squamous cell carcinoma cells Corrigendum in /10.3892/ijo.2016.3702. Int J Oncol 42: 873-880, 2013</div>
					</div>
					<div>
						<div class="citationFormat">APA</div>
						<div class="citation">Yamamura, M., Noguchi, K., Nakano, Y., Segawa, E., Zushi, Y., Takaoka, K. ... Urade, M. (2013). Functional analysis of Zyxin in cell migration and invasive potential of oral squamous cell carcinoma cells Corrigendum in /10.3892/ijo.2016.3702. International Journal of Oncology, 42, 873-880. https://doi.org/10.3892/ijo.2013.1761</div>
					</div>
					<div>
						<div class="citationFormat">MLA</div>
						<div class="citation">Yamamura, M.,  Noguchi, K.,  Nakano, Y.,  Segawa, E.,  Zushi, Y.,  Takaoka, K.,  Kishimoto, H.,  Hashimoto-Tamaoki, T.,  Urade, M.&quot;Functional analysis of Zyxin in cell migration and invasive potential of oral squamous cell carcinoma cells Corrigendum in /10.3892/ijo.2016.3702&quot;. International Journal of Oncology 42.3 (2013): 873-880.</div>
					</div>
					<div>
						<div class="citationFormat">Chicago</div>
						<div class="citation">Yamamura, M.,  Noguchi, K.,  Nakano, Y.,  Segawa, E.,  Zushi, Y.,  Takaoka, K.,  Kishimoto, H.,  Hashimoto-Tamaoki, T.,  Urade, M.&quot;Functional analysis of Zyxin in cell migration and invasive potential of oral squamous cell carcinoma cells Corrigendum in /10.3892/ijo.2016.3702&quot;. International Journal of Oncology 42, no. 3 (2013): 873-880. https://doi.org/10.3892/ijo.2013.1761</div>
					</div>
				</div>
			</div>
		</div>

		<!-- Used to generate counter -->
		<input type="hidden" id="doid" value="10.3892/ijo.2013.1761" />
		<input type="hidden" id="toa"
			value="F" /> <input
			type="hidden" id="ptvstatus" value="F12" />
		<input type="hidden" id="user_id"
			value="" />
		<input type="hidden" id="journal_id" value="ijo" /> <input
			type="hidden" id="alert_track_citation_message"
			value="" />

		<script src="/resources/js/counter.js"></script>
		<script type='text/javascript'
			src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'></script>
		<script type="text/javascript">var addthis_config = addthis_config||{}; addthis_config.data_track_addressbar = false;</script>
		<script type="text/javascript"
			src="https://s7.addthis.com/js/300/addthis_widget.js#pubid=ra-4fe476482ba42f68"></script>

		<script async="async" crossorigin="anonymous"
			src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
		<script src="https://code.jquery.com/ui/1.11.1/jquery-ui.min.js"></script>
		<script src="https://cdn.tiny.cloud/1/560gz528beukra3kb9syq7iido8yu0in5iysfds42lt1q48q/tinymce/4.5.7-72/tinymce.min.js" type="text/javascript"></script> 


		<!-- Add fancyBox main JS and CSS files -->
		<script type="text/javascript"
			src="/resources/js/jquery.fancybox.js"></script>
		<script src="/resources/js/jquery.jgrowl.min.js"
			type="text/javascript"></script>

		<script>
    /*<![CDATA[*/
    	var articleId = 23585;
        $(document).ready(function () {
        	$(".rightsReservedCrossref").html((new Date()).getFullYear()-1);
        	        	
        	$("html, body").animate({"scrollTop":$("#titleId").offset().top}, 1000); 
        	
        	if(!Cookies.get('spandidos-gdpr')) {
        	 $('#navbar').show();
    		
        	$(window).scroll(function() {
          		 if($(window).scrollTop() + $(window).height() > $(document).height() - 50) {
          			 $('#navbar').hide();
          		   }
          		 if($(window).scrollTop() + $(window).height() <= $(document).height() - 50) {
          			 $('#navbar').show();
          		   }
          		});
    		 }
        	
            /* citation */
            
            $('#citation').on('click', '.citedBy', function (e) {
                e.preventDefault();
				if ($('#citations').html() != "") {
	                $("#citationDiv").show();				
				}
            });
            
            $('#citationAllArticlesId').on('click', '.citedBy', function (e) {
                e.preventDefault();
				if ($('#citations').html() != "") {
	                $("#citationDiv").show();				
				}
            });
            
            
            var urlTotalCount = $(".citedByCountId").attr('href');
            $.ajax({url: urlTotalCount, cache: false, success: function (result) {

	                if (result) {
	                	
	                	var count = result;
	                	
	                	if (count > 0) {
		                    $("#citationDiv").hide();
	    	                //$("#citations").html(result);
	        	        } else {
	        	        	$("#citedByIdViewArticles").text("No Articles");
	        	        }
	                	$("#citationCount").html(count);
	                	makeCitationsVisible();
	                } else {
	                	$("#citationCount").html(0);
	                	$("#citedByIdViewArticles").text("No Articles");
	                }
            	}

            });
            
            var url = $(".citedBy").attr('href');
            $.ajax({url: url, cache: false, success: function (result) {

                if (result) {
                	var items = $(result).children();
                	var count = items.length;
                	if (count > 0) {
	                    $("#citationDiv").hide();
    	                $("#citations").html(result);
    	                
    	                $("#citedByIdViewArticles").text("View Articles"); 
    	                
        	        }
                	
                	
                	//$("#citationCount").html(count);
                	makeCitationsVisible();
	                } else {
	                	//$("#citationCount").html(0);
	                	 $("#citedByIdViewArticles").text("No Articles"); 
	                }
            	}
            
            
            
            
            }); 
       
            
           var urlMoreLikeThis = $(".moreLikeThis").attr('href');
            $.ajax({url: urlMoreLikeThis, cache: false,success: function(result){
            	$("#moreLikeThisDiv .moreLikeThisClassFragment").html( $("#moreLikeThisUl", result) );   
		    }});

            /* Simple image gallery. Uses default settings */
            $('a.fancybox').fancybox({
                maxWidth: 1000,
                maxHeight: 800,
                helpers: {
                    title: {
                        type: 'inside'
                    }
                }
            });
        });
        
	var doi= $("#doid").val().split("/")[1];
	     	 $.ajax({
        	    type: "GET",
        	    url: "/retrieveArticleDownloadsAndViews/" +  doi, 
        	    dataType: "json",
        	    success: function(data, textStatus, jqXHR) {
        	   
       
        	    if (data!=null) {	    			
	    		  $("#postFullArticleViews").html(data.fullTextCount);
	    		  $("#postArticleDownloads").html(data.pdfCount);
	   			  $("#postPMCFullArticleViews").html(data.pmcFullTextCount);
	   			  $("#postArticlePMCDownloads").html(data.pmcPdfCount);
	   			  $("#postTotalFullArticleViews").html(data.totalFullTextCount);
	   			  $("#postTotalArticleDownloads").html(data.totalPdfCount);
	    	   	}
	    		else  {
	   			  $("#postFullArticleViews").html(0);
	   			  $("#postArticleDownloads").html(0);
	   			  $("#postPMCFullArticleViews").html(0);
	   			  $("#postArticlePMCDownloads").html(0);
	   			  $("#postTotalFullArticleViews").html(0);
	   			  $("#postTotalArticleDownloads").html(0);
	   	      }
		    },
        	   error: function (jqXHR, textStatus, errorThrown) {
		    }
		});
        
	     	 
	    function makeCitationsVisible(){
	    	try{
        		var searchAttribute = $(location).attr('search');
        		if (searchAttribute == '?citations' ) {
        			if ($('#citations').html() != "") {
	                	$("#citationDiv").show();				
					}
        		}
        	} catch (err) {
        		
        	}
	    }
	    
	    $('#toggleSM').click(function() {
	   		 $('.toggleSM').toggle();
		 });
	    
	   
	    $('#toggleSF').click(function() {
	   		 $('.toggleSF').toggle();
		 });
	    
	    
	    
	    $('#toggleMostCitedDimensions').click(function() {
	   		$('.toggleMostCitedDimensions').toggle();
		});
        
        $('#toggleMostCitedCrossRef').click(function() {
	   		$('.toggleMostCitedCrossRef').toggle();
		});
        
        $('#toggleRef').click(function() {
	   		 $('.toggleRef').toggle();
		 });
        
        $('#toggleFig').click(function() {
	   		 $('.toggleFig').toggle();
		 });
        
        var userId= $("#user_id").val();  
        if(userId!='') {
        $.ajax({
    		type: "GET",
   	   		 url: "/retrieveUserSelectedArticle/" + userId +"/" +  doi, 
   	    	dataType: "json",
   	    	success: function(data, textStatus, jqXHR) {
	  		 if (data) {
   				$('#track_citation').css("display", "none"); ;
   				$('#remove_track_citation').css("display", "block");
   	   		 }
   			else  {
   				$('#track_citation').css("display", "block") ;
   				$('#remove_track_citation').css("display", "none");
  	      	}
	   	 	},
   	   		error: function (jqXHR, textStatus, errorThrown) {
	   		 }    	
		});
        } else {
        	$('#track_citation').css("display", "block");
				$('#remove_track_citation').css("display", "none");
        }
        
        $(window).bind("load", function() {
        	var messsageTrackCitation= $('#alert_track_citation_message');	 
        	
        	if(messsageTrackCitation.length>0  && messsageTrackCitation.val()!=null && messsageTrackCitation.val()!='') {	         		
        		$.jGrowl( messsageTrackCitation.val());
        	 }
         });             
              
        /*]]>*/
    </script>


	</div>
	<!-- End Wrapper -->
</body>

</html>